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ABSTRACT 
 
Background 
Despite the programmes of malaria control the incidence of mortality from 
severe malaria (SM) continues to rise. This is mainly attributable to the fact 
that the pathophysiological mechanisms are still not clearly defined.  
Objectives 
This project investigated the endocrine and paracrine aspects of the 
pathophysiology of SM in children. The study monitored relevant clinical 
and laboratory parameters of SM cases on admission so as to identify and 
correct life threatening changes.  
Patients and Methods 
This is a cross sectional study conducted at Wadmedani Paediatric Hospital 
from September 2007 to September 2008. Fifty six Children with SM, 
identified according to WHO criteria, were included in the study. Thirty one 
children with uncomplicated malaria (UM) were included for comparison. 
Both groups underwent a history and physical examination. Investigations 
included: parasitemia, Hb, RBG, TWBC, liver enzymes, bilirubin, urea, 
creatinine, sodium, potassium and cytokines (TNF-α, IFN-γ, IL-10). 
Statistical analysis was carried out with SPSS for windows. Means were 
analyzed by student’s T test. Correlations were analyzed using χ2 tests, 
Pearson's correlation coefficient and Spearman' rank correlation coefficient 
tests. Assessments of prognostic factors were conducted with regression 
model. P values < 0.05 were considered significant.  
Results 
Children with SM were younger than those with UM (mean age=56.75 
months compared to 82.71 months, P value= 0.001).  
 
 V
A significant difference was found in the mean RBG between children with 
SM and UM (89.27±39.06 compared to 108.06±39.14 mg/dl respectively) P 
value= 0.035 as well as in the mean Hb (7.54±2.71 compared to 9.91±1.67 
mg/dl respectively, P value= 0.000). 
The pattern and cytokines secretion levels showed higher mean TNF-α in 
children below 5 years old and in children with CM. Those above 5 years 
had higher IFN-γ which was found to correlate positively with Hb, RBG, 
splenomegaly and hepatomegaly. Children with SA had a lower IFN-γ and 
IL-10 when compared to UM.  
Conclusions 
SA may result from haemolysis of red blood cells, low level of IFN-γ and 
IL-10. 
Glucose consumption by the parasites and low IFN-γ may be the causes of 
hypoglycemia. 
CM, mixed presentation, young age and hyperkalaemia were independently 
associated with increased risk of morbidity and mortality. High bilirubin, 
high TWBCs counts, high urea, high creatinine, low Hb and low RBG were 
significantly associated with CM and mixed presentation. 
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 ﻣﻠﺨﺺ اﻟﺪراﺳﺔ
 ﺧﻠﻔﻴﺔ
وهﺬا ﻳﻌﺰي . ﻓﻲ ارﺗﻔﺎع ﻣﺴﺘﻤﺮ ﻣﺎزاﻟﺖ اﻟﻤﻼرﻳﺎ اﻻ ان ﻣﻌﺪل اﻟﻮﻓﻴﺎتﻋﻠﻲ اﻟﺮﻏﻢ ﻣﻦ ﺑﺮاﻣﺞ ﻣﻜﺎﻓﺤﺔ 
 اﺳﺎﺳﺎ اﻟﻲ ﺣﻘﻴﻘﺔ ان َاﻟﻴﺎت اﻟﻔﺴﻴﻮﻟﻮﺟﻴﺎ اﻟﻤﺮﺿﻴﺔ ﻻﺗﺰال ﻏﻴﺮ ﻣﻌﺮوﻓﺔ 
  ﻻهﺪافا
ﺗﺮﺻﺪ هﺬﻩ اﻟﺪراﺳﺔ اﻟﻤﺆﺷﺮات . هﺬﻩ اﻟﺪراﺳﺔ ﺗﺒﺤﺚ ﻓﻲ اﻟﻔﺴﻴﻮﻟﻮﺟﻴﺎ اﻟﻤﺮﺿﻴﺔ ﻟﻠﻤﻼرﻳﺎ اﻟﻮﺧﻴﻤﺔ 
ﺒﻜﺮة ﻟﻠﻤﺮض وذﻟﻚ ﻟﺘﺤﺪﻳﺪ وﺗﺼﺤﻴﺢ اﻟﺘﻐﻴﻴﺮات اﻟﺘﻲ ﺗﻬﺪد اﻟﺴﺮﻳﺮﻳﺔ واﻟﻤﻌﻠﻤﻴﺔ ﺧﻼل اﻟﻤﺮاﺣﻞ اﻟﻤ
  .اﻟﺤﻴﺎة
  :اﻟﻤﺮﺿﻲ واﻟﻮﺳﺎﺋﻞ
اﺟﺮﻳﺖ هﺬﻩ اﻟﺪراﺳﺔ ﻓﻲ ﻣﺴﺘﺸﻔﻲ  .ﻳﻘﻮم هﺬا اﻟﺒﺤﺚ ﻋﻠﻲ دراﺳﺔ ﻣﻘﻄﻌﻴﺔ ﻋﻠﻲ ﻣﺠﻤﻮﻋﺔ ﻣﻦ اﻟﻤﺮﺿﻲ
ﻃﻔﻞ ﻳﻌﺎﻧﻮن  65ﺷﻤﻠﺖ اﻟﺪراﺳﺔ . 8002ﺣﺘﻲ ﺳﺒﺘﻤﺒﺮ 7002ودﻣﺪﻧﻲ ﻟﻼﻃﻔﺎل ﻓﻲ اﻟﻔﺘﺮة ﻣﻦ ﺳﺒﺘﻤﺒﺮ 
 13ﺷﻤﻠﺖ اﻟﺪراﺳﻪ اﻳﻀُﺎ. ﻴﻤﺔ وﻗﺪ ﺗﻢ ﺗﺤﺪﻳﺪهﻢ وﻓﻘﺎ ﻟﻤﻌﺎﻳﻴﺮ ﻣﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﻟﻤﻴﺔﻣﻦ اﻟﻤﻼرﻳﺎ اﻟﻮﺧ
 اﻟﻤﺠﻤﻮﻋﺘﻴﻦ ﺧﻀﻌﺖ ﻟﻠﻔﺤﺺ اﻟﺴﺮﻳﺮيﺎ ﻃﻔﻞ ﻣﻦ اﻟﺬﻳﻦ ﻳﻌﺎﻧﻮن ﻣﻦ اﻟﻤﻼرﻳﺎ ﻏﻴﺮ اﻟﻮﺧﻴﻤﺔ آﻠﺘ
ﻠﻮﺑﻴﻦ، ﻋﺪد آﺮﻳﺎت اﻟﺪم اﻟﺒﻴﻀﺎء ، ﻏﻣﻌﺪل ﺗﻮاﺟﺪ اﻟﻄﻔﻴﻞ، اﻟﻬﻴﻤﻮ: اﻟﺘﺎﻟﻴﺔ واﻻﺧﺘﺒﺎرات اﻟﻤﻌﻤﻠﻴﻪ
  اﻻﺗﻴﻪ ﺎﻳﺘﻮآﺎﻳﻨﺎتﺴاﻟو  مﻮاﻟﺒﻴﻠﻮروﺑﻴﻦ ، اﻟﺒﻮﻟﻴﻨﺎ ، اﻟﻜﺮﻳﺎﺗﻴﻨﻴﻦ ، اﻟﺼﻮدﻳﻢ ، اﻟﺒﻮﺗﺎﺳﻴ اﻧﺰﻳﻤﺎت اﻟﻜﺒﺪ،
 )01-LI ,γ-NFI ,α-FNT(. اﺳﺘﺨﺪم    SSPS ﻗﻮرﻧﺖ اﻟﻤﺘﻮﺳﻄﺎت ﺑﺎﺧﺘﺒﺎر. ﻟﻠﺘﺤﻠﻴﻞ اﻻﺣﺼﺎﺋﻰ 
 s'nosraeP    و stset 2χ ﻟﺘﺤﻠﻴﻞ اﻻرﺗﺒﺎﻃﺎت اﺳﺘﺨﺪﻣﺖ اﻻﺧﺘﺒﺎرات اﻻﺗﻴﻪ tset T s’tneduts.
  .stset tneiciffeoc noitalerroc knar 'namraepS dna tneiciffeoc noitalerroc
اﻋﺘﺒﺮت ﻓﺮق  50.0اﻗﻞ ﻣﻦ  P ﺔﻗﻴﻤ. ledom noisserger ﺗﻘﻴﻴﻢ اﻟﻌﻮاﻣﻞ اﻟﺘﻨﺒﺆﻳﻪ اﺟﺮى ﺑﻮاﺳﻄﺔ
 .ﻣﻌﻨﻮى
  :اﻟﻨﺘﺎﺋﺞ
اﻻﻃﻔﺎل اﻟﻤﺼﺎﺑﻮن ﺑﺎﻟﻤﻼرﻳﺎ اﻟﻮﺧﻴﻤﺔ آﺎﻧﻮا ﻣﻦ ذوي اﻻﻋﻤﺎر اﻟﺼﻐﻴﺮة ﻣﻘﺎرﻧﺔ ﺑﻤﺮﺿﻲ اﻟﻤﻼرﻳﺎ ﻏﻴﺮ 
  100.0=Pﻗﻴﻤﺔ  (ﺷﻬﺮ 17.28 ﻣﻘﺎرﻧﻪﺷﻬﺮ 57.65ﻣﺘﻮﺳﻂ اﻟﻌﻤﺮ)ﻟﻮﺧﻴﻤﺔ ا
وﺟﺪ ﻓﺮق ﻣﻌﻨﻮي ﻓﻲ ﻣﺴﺘﻮي اﻟﺠﻠﻜﻮز ﻓﻲ اﻟﺪم ﺑﻴﻦ ﻣﺮﺿﻲ اﻟﻤﻼرﻳﺎ اﻟﻮﺧﻴﻤﺔ وﻏﻴﺮ اﻟﻮﺧﻴﻤﺔ  
 آﺬاﻟﻚ ﻓﻰ  530.0=Pﻗﻴﻤﺔ  (دﺳﻠﺘﺮ ﻋﻠﻲ اﻟﺘﻮاﻟﻲ /ﻣﻠﺠﻢ 41.93±6.801 -  60.93±72.98)
 . 000.0=Pﻗﻴﻤﺔ  (دﺳﻠﺘﺮ ﻋﻠﻲ اﻟﺘﻮاﻟﻲ /ﻣﻠﺠﻢ 76.1±19.9-دﺳﻠﺘﺮ  /ﻣﻠﺠﻢ17.2±45.7) ﻠﻮﺑﻴﻦﻏاﻟﻬﻴﻤﻮ
IIV 
اﻻﻃﻔﺎل  .ﻋﻨﺪ ﻣﺮﺿﻲ اﻟﻤﻼرﻳﺎ اﻟﺪﻣﺎﻏﻴﺔآﻤﺎ ارﺗﻔﻊ  α-FNTاﻻﻃﻔﺎل دون ﺳﻦ اﻟﺨﺎﻣﺴﺔ ارﺗﻔﻊ ﻟﺪﻳﻬﻢ 
ﻠﻮﺑﻴﻦ ، ﻏاﻟﻬﻴﻤﻮﻣﻊ  ارﺗﺒﺎط اﻳﺠﺎﺑﻲ  ﻳﺮﺗﺒﻂ ﻪوﺟﺪ اﻧ اﻟﺬى γ-NFIﻓﻮق ﺳﻦ اﻟﺨﺎﻣﺴﺔ ارﺗﻔﻊ ﻟﺪﻳﻬﻢ 
-LI و γ-NFIﻟﺤﺎد ﻧﻘﺺ ﻋﻨﺪهﻢ ﻣﺴﺘﻮي ﻘﺮ اﻟﺪم اﻣﺮﺿﻲ ﻓ. ﺎل وﺗﻀﺨﻢ اﻟﻜﺒﺪﺗﻀﺨﻢ اﻟﻄﻮﺣ ،اﻟﺠﻠﻜﻮز
   .اﻟﺬﻳﻦ ﻻﻳﻌﺎﻧﻮن ﻣﻦ ﻓﻘﺮ اﻟﺪم اﻟﺤﺎد و ﺑﻤﺮﺿﻲ اﻟﻤﻼرﻳﺎ ﻏﻴﺮ اﻟﻮﺧﻴﻤﺔ اآﺜﺮ ﻋﻨﺪ اﻟﻤﻘﺎرﻧﺔ 01
  اﻟﺨﻼﺻﻪ
ﺗﺜﺒﻴﻂ ﻋﻤﻠﻴﺔ ﺗﺼﻨﻴﻊ آﺮﻳﺎت اﻟﺪم اﻟﺤﻤﺮاء وﻧﻘﺺ ، ﻓﻘﺮ اﻟﺪم اﻟﺤﺎد ﻳﻨﺘﺞ ﻋﻦ ﺗﻜﺴﺮ آﺮﻳﺎت اﻟﺪم اﻟﺤﻤﺮاء
  .01-LI و  γ-NFIﻣﺴﺘﻮى 
اﻟﺴﺎﻳﺘﻮآﺎﻳﻦ واﻧﺨﻔﺎض ﻳﻨﺘﺞ ﻋﻦ إﺳﺘﻬﻼك اﻟﻄﻔﻴﻞ اﻟﻤﺒﺎﺷﺮ ﻟﻠﺠﻠﻜﻮز  رﺑﻤﺎ ﻠﻜﻮز اﻟﺤﺎدإﻧﺨﻔﺎض اﻟﺠ
   γ-NFI
 
اﻟﻌﻤﺮ اﻟﺼﻐﻴﺮ وإرﺗﻔﺎع اﻟﺒﻮﺗﺎﺳﻴﻮم ﻓﻰ اﻟﺪم ﻟﺪﻳﻬﺎ إرﺗﺒﺎط ، اﻟﻤﻀﺎﻋﻔﺎت اﻟﻤﺘﻌﺪدﻩ، اﻟﻤﻼرﻳﺎ اﻟﺪﻣﺎﻏﻴﻪ
إرﺗﻔﺎع ، إرﺗﻔﺎع ﻋﺪد آﺮﻳﺎت اﻟﺪم اﻟﺒﻴﻀﺎء، إرﺗﻔﺎع اﻟﺒﻴﻠﻮروﺑﻴﻦ. ﺑﺰﻳﺎدﻩ ﻣﻀﺎﻋﻔﺎت ووﻓﻴﺎت اﻟﻤﻼرﻳﺎ
ﻨﻮﻳﺎ ﺑﺎﻟﻤﻼرﻳﺎ ارﺗﺒﻄﺖ ﻣﻌ اﻧﺨﻔﺎض اﻟﻬﻴﻤﻮﻏﻠﻮﺑﻴﻦ واﻧﺨﻔﺎض اﻟﺠﻠﻜﻮز، إرﺗﻔﺎع اﻟﻜﺮﻳﺎﺗﻨﻴﻦ، اﻟﺒﻮﻟﻴﻨﺎ
  .اﻟﻤﻀﺎﻋﻔﺎت اﻟﻤﺘﻌﺪدﻩ و اﻟﺪﻣﺎﻏﻴﻪ
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    CHAPTER ONE 
INTRODUCTION 
 
Malaria is one of most common parasitic disease. It is caused by obligate 
intracellular parasites, which live in host erythrocytes and remodel these 
cells to provide their own needs. It is a major public health problem in 
tropical areas, and it is estimated that malaria is responsible for 1 to 3 
million deaths and 400–900 million infections annually (1). Eighty 
percent of the deaths occur during the first 24 hours following admission 
(2, 3).  The vast majority of morbidity and mortality from malaria is 
caused by infection with Plasmodium falciparum, although P. vivax, P. 
ovale, and P. malariae are also responsible for human infection. Since its 
discovery the problems of controlling the disease are far from being 
solved and endemicity is increasing. Emergence of parasite resistance to 
available drugs, recrudescence, recurrence and the complex 
pathophysiology of the infection process complicate treatment regimens. 
 
Children of all ages living in nonmalarious areas are equally susceptible 
to malaria. In endemic areas, children younger than 5 years have repeated 
and often serious attacks of malaria. The survivors develop partial 
immunity at the time of adolescence (4). Older children and adults often 
have asymptomatic parasitemia ie presence of plasmodia in the 
bloodstream without clinical manifestations of malaria while the episodes 
of malaria and its severity are decreased. A lack of acquired immunity to 
P. falciparum malaria in young children appears to underlie the high rates 
of morbidity and mortality from malaria in areas of sub-Saharan Africa 
where malaria is endemic.  
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Malaria endemicity 
Malaria endemicity varies between different parts of the world and even 
within a country. It is defined by spleen rate in children aged 2-9 years. In 
hypoendemic areas, the spleen rate of children range is 0-10%, in 
mesoendemic areas the spleen rate is 10-50%, in hyperendemic areas 
spleen rate is 50-70% and in holloendemic areas the spleen rate is more 
than 70%.  
Malaria endemicity in Sudan 
Malaria is the main endemic parasitic disease in Sudan. Malaria incidence 
in Sudan was estimated to be about 9 million per year and the number of 
deaths due to malaria about 44,000. Children under 5 years of age had the 
highest burden (5). 
  
Malaria transmission in eastern, western and northern states of Sudan is 
low to moderate, highly seasonal and occasionally epidemic. In the 
southern state transmission is generally perennial with moderate to high 
intensity.  Plasmodium falciparum is the dominant species account for 
95% of cases and the major anopheles vector is anopheles arabiensis (6). 
   
Despite efforts directed toward malaria control, malaria still is a major 
killer of children in Africa. The pathophysiological mechanisms of severe 
malaria are still not fully understood. Better understanding of these 
mechanisms may lead to discovery of new drugs and methods of 
preventions. This may have great advantage in the face of increase 
parasite resistance to available drugs. Detecting bad prognostic indicators 
in severe malaria could aid clinicians caring for children with severe 
malaria to avoid diagnostic delays, identify the children most likely to die 
and thus improve management by targeting resources to children at 
higher risk. 
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This study will attempt to monitor physiological and metabolic variables 
in children with severe malaria so as to identify the more reliable 
indicators of serious outcomes. The ultimate aim is to consider severe 
malaria as an indication for intensive care. For this to take place, cost 
effective variables associated with fatal outcomes have to be identified. 
This work will look at biochemical, hormonal, haematologic and 
inflammatory parameters associated with morbidity and mortality. 
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LITERATURE REVIEW 
Malaria parasite life cycle 
Human malaria is caused five Plasmodium species: P. falciparum, P. 
vivax, P. ovale, plasmodium knowlesi and P. malariae. The life cycle of 
malaria parasites is complex, with asexual reproduction occurring in the 
mammalian host and sexual reproduction in the anopheline mosquito 
vector. The parasites are transmitted to humans in the form of sporozoites 
through the bite of a female anopheline mosquito. The sporozoites 
circulate for up to 45 min before entering hepatocytes, in which they 
undergo asexual reproduction to form a large intracellular schizont. The 
swollen hepatocyte eventually bursts, discharging merozoites into the 
bloodstream, where they rapidly invade erythrocytes to initiate the 
erythrocytic cycle. In P. vivax and P. ovale infections, dormant liver 
forms also occur that are capable of reactivating and forming a hepatic 
schizont weeks or months later. The blood stage merozoite is surrounded 
by complex membranes and contains nucleus, mitochondria, endoplasmic 
reticulum, ribosomes, cytosome and apical membrane organelles called 
rhoptries and micronemas. Inside the erythrocyte, the merozoites lose the 
complex membranes and apical organelles and develops within a 
membrane-bound parasitophorous vacuole first as a trophozoite and then, 
during multiple nuclear division known as schizogony, as a schizont. 
When the schizont matures, the host red blood cell ruptures and liberates 
merozoites that rapidly invade fresh erythrocytes in the general 
circulation, thus continuing the life cycle. Some merozoites develop into 
sexual forms (gametocytes), which are taken into the mosquito gut with a 
blood meal. These may fuse forming a zygote and then undergo meiosis 
to form first an ookinete and later an oocyst in the gut wall. This phase of 
multiplication in the mosquito is known as sporogony. The oocyst bursts, 
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liberating large numbers of sporozoites that migrate to the salivary glands 
to await injection into the human host during the next blood meal.  
Clinical presentation of malaria 
The spectrum of the clinical presentation and severity of P. 
 falciparum infection is broad and vary from asymptomatic infection to 
severe malaria. In endemic areas, many infections in semi-immune and 
immune children and adults present as uncomplicated febrile illness. 
Nonimmune individuals may exhibit a number of complications including 
anaemia, coma, respiratory distress, and hypoglycemia. Many factors 
were found to affect clinical presentation of malaria. Transmission rate 
and age independently affect the clinical presentation. In areas where 
malaria transmission rate is high, severe malaria tends to affect children 
younger than 5 years while older children and adult tend to have the 
uncomplicated malaria. In low endemic areas, severe malaria affects 
older children as well (7). 
   
Age is found to be another factor affecting the clinical presentation of 
malaria in children. The age distribution of the severe malaria categories 
is striking, but poorly understood. Children born in endemic areas are 
largely protected from severe malaria in the first 6 months of life by the 
passive transfer of maternal immunoglobulins and by fetal haemoglobin 
(8). The presentation of disease changes from severe anaemia in children 
aged less than five years to cerebral malaria in older children in areas of 
higher transmission (9). 
 
The differences caused by rate of transmission and age on clinical 
presentation of malaria can be explained by the time of acquisition of 
immunity. Immunity against malaria develops slowly with increasing age. 
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Uncomplicated malaria 
Fever is the main presenting feature of malaria together with chills and 
shivering. Headache, Malaise, nausea, vomiting and diarrhea may also 
present. Fever is irregular at beginning of infection but if left untreated, 
malaria paroxysm appear. Malaria paroxysm is composed of a cold stage 
into which the patient feels cold due to vasoconstriction and shivering. 
Second stage is hot stage in which temperature rises and the skin is hot 
and dry. In the third stage sweating occurs and temperature falls. The 
paroxysm regularizes to two day cycle in plasmodium ovale and vivax 
(tertian malaria) while in plasmodium malariae and falciparum it 
regularizes to three day cycle (quartan malaria). Hepatosplenomegaly 
may develop during the course of the disease. 
Severe malaria 
Children with severe malaria may have the symptoms and signs of 
uncomplicated malaria mentioned above with one or more of WHO 
criteria of severe malaria (10). 
WHO criteria of severe malaria in children: 
• Cerebral malaria: unarousable coma for more than 30 minutes. 
• Severe anaemia: Hb less than 5 g/dl or PCV less than 15%. 
• Renal failure: creatinine more than 3mg/dl.  
• Pulmonary edema 
• Hypoglycemia: whole blood glucose less than 40mg/dl. 
• Circulatory collapse or shock: systolic blood pressure less than 
50mmhg. 
• Repeated generalized convulsions: more than two attacks per 24 
hours despite cooling. 
• Disseminated intravascular coagulation with laboratory evidence. 
• Acidemia: arterial pH less than 7.25 or HCO3 less than 15 mmol /l. 
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• Macroscopic haemoglobinuria 
Other features, mentioned by WHO, but do not constitute features of 
severe malaria are:- 
• Impaired consciousness but less marked than unarousable coma 
• Prostration 
• Hyperparasitemia more than 5%.  
• Jaundice: total bilirubin more than 3mg/dl. 
• Hyperpyrexia: rectal temperature more than 40°C 
Pathophysiology of severe malaria:  
The pathogenesis of severe malaria may be attributed to distinct pattern 
of dysregulation of the immune system to infection which can result in 
different disease categories of severe malaria (11). The following is a 
review of the role of cytokines in the pathogenesis and the immune 
response 
Overview of immunity and cytokines in malaria 
The immune system is a network of cells, proteins, tissues, and organs 
that work together to protect the body against infection or other insults. 
The immune system is composed of two major components: innate 
immunity which provides a general response against invasion by a wide 
range of antigens, and adaptive immunity which develops upon exposure 
to antigens. Cells associated with the immune system are leukocytes. 
There are two main categories of leukocytes; the phagocytes 
(granulocytes, monocytes, and macrophages) and lymphocytes. 
Lymphocytes are further categorized as T lymphocytes (including helper, 
cytotoxic, and suppressor T cells), B lymphocytes, and natural killer cells. 
T lymphocytes kill foreign cells through chemical lyses and help B 
lymphocytes in specific immune functions. B cells secrete antibodies that 
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help in foreign cells destruction. Natural killer cells target viruses and 
tumors. 
Cytokines are messengers that allow the various immune cells to 
communicate with each other and elicit certain responses. Cytokines are 
small proteins range from 5-20 KD produced by leukocytes and other 
cells. They differ from the classical hormones in that they are secreted by 
many cell types rather than specialized gland and their action is paracrine 
and autocrine rather than endocrine. Cytokines include interleukins, 
lymphokines, chemokines, some growth factors like TGF-alpha and TGF-
beta and related signaling molecules such as TNF and IFN.  
Immune systems use cytokines in homeostatic mechanisms and to 
provide signals important in host responses to invading organisms. 
Cytokines initiate and amplify inflammation by recruiting and activating 
cells, regulate the activation and differentiation of T- and B-lymphocytes 
and initiate and regulate local repair processes important for resolution of 
inflammatory responses. Cytokines act through cell receptors, which 
relay a signal into the cell triggering a response. Cytokine-receptors 
interactions are promiscuous, pleiotropic and redundant. 
Cytokines member 
The Interleukins 
Interleukins are a group of cytokines produced predominantly by 
macrophages and lymphocytes. 
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Some interleukins and their functions: 
Name Source Functions 
IL-1 macrophages 
-Induce acute phase inflammatory reactions& 
fever. 
-Activate lymphocytes and phagocytes 
IL-2 TH1-cells Stimulates growth and differentiation of T cell response.  
IL-3 T cells Stimulates bone marrow stem cells 
IL-5 TH2-cells Has role in differentiation of B cells, eosinophil production, and IgA production 
IL-6 macrophages, TH2-cells Induces acute phase reaction 
IL-7 - Involved in B, T, and NK cell survival, development, and homeostasis 
IL-8 -  Involved in neutrophil chemotaxis 
IL-10  Macrophags, TH2-cells Suppress proinflammatory cytokines secretion 
IL-12 macrophages Involved in NK cell stimulation, Th1 cells induction 
IL-18 - Induces production of IFN-γ 
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IL-10 
IL-10 is secreted by certain T lymphocytes subsets (Thelper 2 and T 
regulatory cells), monocytes and macrophages but the major source is the 
macrophage. Secretion is stimulated by endotoxin, TNF-α, cAMP 
elevating drugs, catecholamines and Stress. IL-10 is a homodimer made 
of two subunits with molecular mass of 37 KDa. IL-10 receptors found 
on the surface of cells and belong to cytokine receptor family type 2.  
 
Human IL-10 was found to act as an antiinflammatory agent able to block 
the production of IL-6, TNF-a, IL-1 and other cytokines by 
monocytes/macrophages (12). This property, together with an inhibitory 
effect on the expression of MHC class II antigens on 
monocytes/macrophages results in inhibition of the antigen presenting 
capacity of these cells, and a consequent inhibition of T lymphocyte 
proliferation (13). In addition, IL-10 was recently shown to induce the 
proliferation of B lymphocytes and their differentiation into plasma cells 
secreting immunoglobulins at high rate (14, 15). Taken together, IL-10 
inhibits cellular immunity reactions and stimulates humoral responses. 
IL-10 was also found to decrease platelet production (16). 
 
Numerous in vitro and animal experiments suggest a major impact of IL-
10 in inflammatory, malignant, and autoimmune diseases. IL-10 over 
production was found in certain inflammatory disorders like rheumatoid 
arthritis and systemic lupus erythromatosis (17, 18). In contrast, a relative 
IL-10 deficiency has been observed and is regarded to be of 
pathophysiological relevance in certain inflammatory disorders 
characterized by a type 1 cytokine pattern such as psoriasis (19). 
Recombinant human IL-10 has been produced and is currently being 
tested in clinical trials. This includes psoriasis and organ transplantation 
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(19, 20). IL-10 administered to healthy volunteers was well tolerated 
without serious side effects at doses up to 25µg/kg, mild to moderate flu-
like symptoms were observed in a fraction of recipients at doses up to 
100µg/kg. A single subcutaneous dose of IL-10 resulst in transient 
neutrophilia, lymphocytopenia, and monocytosis and delayed decrease in 
platelet counts (21). 
 
Chemokines 
Chemokines are small proteins secreted by cells. These molecules 
classified as chemokines according to structural characteristics e.g the 
small size of 8- 10 kilodalton and having four cystiene residues which 
determine the three-dimensional shape of the molecule.  
They work through paracrine chemotaxis and interaction with G protein-
linked transmembrane receptor on target cells. Chemokine receptors are 
G protein coupled receptors containing 7 transmembrane domains that are 
found on the surface of  WBCs. Activation of G proteins causes the 
subsequent activation of an enzyme phospholipase C(PLC). PLC cleaves 
Phosphatidylinositol (4,5)-bisphosphate (PIP2) into Inositol triphosphate 
(IP3) and diacylglycerol (DAG) that trigger intracellular signaling events; 
DAG activates another protein kinase C (PKC), and IP3 triggers the 
release of calcium from intracellular stores. This in turn leads to 
activation of many cellular pathways which generate responses like 
chemotaxis, degranulation, release of superoxide anions and changes in 
the avidity of cell adhesion molecules called integrins within the cell 
having the chemokine receptor. 
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Interferons 
Interferons (IFNs) are proteins produced by virally infected host cells in 
response to viral double stranded RNA. Different types of IFNs are 
produced by different types of cells; machrophages are the primary 
producers of IFN-α and IFN-β, whereas T lymphocytes release IFN-γ 
There are three types of interferons classified according to the type of 
receptor through which they signal; Interferon type I which binds to the 
IFN-α receptor (IFNAR) that consists of IFNAR1 and IFNAR2 chains, 
Interferon type II binds to IFNGR and interferon type III which signal 
through a receptor complex consisting of IL10R2 and IFNLR1  
The JAK-STAT signaling pathway is the best-characterized IFN 
signaling pathway. 
interferons are antiviral and possess antioncogenic properties, 
macrophage and natural killer lymphocyte activation, and enhancement 
of major histocompatibility complex glycoprotein classes I and II, and 
thus presentation of foreign peptides to T cells. The production of 
interferons is induced by microbes as well as mitogens and other 
cytokines.  
Tumor necrosis factor-alpha 
TNF-α is mainly produced by macrophages, but also by a wide variety of 
cells including lymphoid cells, mast cells, endothelial cells, cardiac 
myocytes, fibroblasts and neuronal tissue. Large amounts of TNF-α are 
released in response to lipopolysaccharide, other bacterial products and 
IL-1. 
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TNF-α is primarily produced as a 212 amino acid-long  transmembrane 
protein arranged in stable homotrimers. From this membrane-integrated 
form the soluble homotrimeric cytokine (sTNF) is released via proteolytic 
cleavage by the metalloprotease TNF alpha converting enzyme.  
Two receptors, TNF-R1 (TNF receptor type 1) and TNF-R2 (TNF 
receptor type 2), bind to TNF. TNF-R1 is expressed in most tissues, and 
can be activated by both the membrane-bound and soluble forms of TNF-
α, while TNF-R2 is only found in cells of the immune system and 
respond to the membrane-bound form of the TNF. Binding of TNF with 
their receptor, leads to a conformational change to occur in the receptor, 
leading to changes in transcription of many proteins involved in cell 
differentiation, proliferation and inflammation.  
TNF-α is involved in systemic inflammation and is a member of a group 
of cytokines that all stimulate the acute phase reaction. TNF-α causes 
apoptotic cell death, cellular proliferation, differentiation, inflammation 
and ihibits tumorigenesis and viral replication. It has anti-apoptotic 
activity as well.  
It has a number of actions on various organ systems, generally together 
with IL-1 and Interleukin-6: On the hypothalamus TNF-α stimulates the 
hypothalamic-pituitary-adrenal axis by stimulating the release of 
corticotropin releasing hormone (CRH) and induction of fever (22, 23).  
On the liver, TNF-α stimulates the acute phase response, leading to an 
increase in C-reactive protein and a number of other mediators (24). It 
also induces insulin resistance by promoting serine-phosphorylation of 
insulin receptor substrate-1 (IRS-1), which impairs insulin signaling (26). 
On other tissues TNF-α increases insulin resistance (25, 26).   
 14
In the immune system, TNF-α was found to attract neutrophils very 
potently, and helps them to stick to the endothelial cells for migration as 
well as enhancing their phagocytostic capacity (27, 28).  
Dysregulation and overproduction of TNF-α have been implicated in the 
pathogenesis of many human diseases (29, 30)  
General properties of cytokines receptors 
Cytokines act on their target cells by binding specific membrane 
receptors. Cytokines interactions with their receptors are characterized by 
being non-specific, pleiotropic, redundant and Polyspeirism. Non-
specificity (promiscuity) means that the binding site of a receptor can 
bind many ligands and a ligand can bind several receptors. The 
pleiotropic characteristic indicates that a single cytokine molecule can 
produce many diverse effects. IFN-γ activates >200 different genes. 
Redundancy means that several agents can perform the same action. 
Although the agents are not identical, they are redundant to the degree to 
which they may replace one another functionally. Chemokines are 
example of a redundant cytokine system. Polyspeirism is a state in which 
multiple cytokines are produced in a redundant way by a single cell 
together in response to the same stimulus. 
Effects of cytokines on the immune system 
Cytokines mediate immunity in three ways; first they mediate natural 
immunity, included in this group IL-1, TNF-α, IFN-α and IL-8. Some of 
these cytokines eg IFN-γ protect against viral infection whereas others eg 
IL-1, TNF- α initiate non specific inflammatory response. Secondly, 
cytokines stimulate lymphocytes growth, differentiation and activation. 
Within this group, IL-2, IL-4, IL-5, IL-12 and TGF-β. Thirdly, cytokines 
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activate inflammatory cells .Within this group, IFN-γ, TNF-α, TNF-β, 
migration inhibitory factor and IL-8. 
  
To responses in a timely and efficient manner, the immune system 
developed numerous mechanisms, including T regulatory cells (Tr cells), 
to modulate and down-regulate immune responses at different stages. Tr 
cells include regulatory Th2 cells (which suppress Th1 associated 
responses), Th1 cells (which suppress Th2-cell-mediated responses), IL-
10-producing Tr1 cells (a subset of IL-10-dependent, antigen-specific 
regulatory T cells), TGF-β1-secreting Th3 cells, CD8+, natural killer T, 
and γδ T cells. Several cytokines including IL-10 and TGF-β1 have been 
implicated in Tr effector functions. 
 
IL-10 down regulates T helper 1 responses, namely IFN-γ secretion and 
activation of monocytes and macrophages. IL-10 controls also Th2-
mediated inflammatory processes. IL-10 also has immunostimulatory 
properties especially on B cells and activated CD8+T cells. However, IL-
10 is able to induce the differentiation of a subset of regulatory CD4+T 
cells (Tr1) and is important for the in vivo function of regulatory T cells 
and these supports the role of IL-10 as an important cytokine in the 
control of immune responses. In different experiments, these cells were 
shown to inhibit Th1 and Th2-type inflammatory responses through the 
secretion of IL-10. These Tr1 cells may thus have important 
pharmacological uses in inflammation. 
Cytokines and immunity in malaria  
Following repeated exposure to infection, people living in malaria 
endemic areas gradually acquire mechanisms to limit the inflammatory 
response to the parasite that causes the acute febrile symptoms as well as 
mechanisms to kill parasites. Children, who have yet to develop 
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protective immune mechanisms are thus at greater risk of clinical malaria, 
severe disease and death than adults. Artaavanis-Tsakonas et al (2003) 
suggested the following model of antimalarial immunity; in endemic 
populations, primary malaria infections in infants induce low levels of 
IFN-γ and TNF-α via an innate pathway and at the same time antigen 
specific T cells are primed. The infection induces minimal clinical 
symptoms and parasites are cleared, either immunologically (via 
opsonization by maternal antibody or cytokine-mediated parasite killing) 
or because parasites fail to establish themselves in the face of 
physiological barriers (e.g. fetal haemoglobin and dietary deficiencies) 
(9). On re-infection, the malaria primed T cells produce greatly increased 
amounts of IFN-γ which synergizes with malarial 
glycosylphosphatidylinositol to up-regulate the production of TNF-α 
leading to an increased risk of severe disease. Further infections induce 
effective antiparasitic immunity which reduces the parasite load and thus 
the concomitant level of antigenic stimulation, thereby dampening the 
pro-inflammatory cytokine cascade. Falling antigen concentrations or 
other factors lead to a switch in the predominant T cell phenotype from 
Th1 (IFN-γ producing) to a regulatory T cell phenotype (IL-10 and TGF-
β producing). Thus immune individual can clear the infection without 
running the risk of overproducing dangerous inflammatory mediators. 
The risk of severe disease may thus depend on the relative speed with 
which the different components of the antimalarial immune response 
develop (31). 
However cerebral malaria, a common manifestation of severe malaria, 
occurs in children who have probably acquired a significant degree of 
antimalarial immunity as evidenced by higher levels of circulating 
antimalarial antibodies (32). The potential explanation is that cerebral 
malaria is, in part, an immune-mediated disease in which αβ T cells 
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priming occurs during first infection and eventually leads to excessive 
IFN-γ and TNF-α production and immunopathology on re-infection (33) 
 
Both innate and adaptive immunity are involved in immunity against 
malaria.  
Innate immunity: 
Innate immunity is thought to play an important role in clearing 
Plasmodium from the infected hosts. Most of the elimination occurs in the 
spleen, although the liver has been shown to be an alternative site (34). 
Cells from the monocyte and macrophage are more effective than 
neutrophils in phagocytosing parasitized erythrocytes (35). Macrophages 
of the red pulp carry out this job specifically (36). Macrophage is 
activated by natural killer cells (NK) and γδ T cells-derived IFN-γ 
enhancing phagocytosis and killing of parasitized erythrocytes (37). 
Recent studies have shown that P. chabaudi infection in γδ T-cell 
deficient mice have exacerbated early and chronic parasitemias (38). 
These results are in accordance with other studies that describe early 
production of IFN-γ and TNF-α both to splenic γδ T lymphocytes and to 
NK cells (39). These results suggest that the early production of both 
cytokines is important in the early control of parasitemia and that both 
natural killer and γδ T cells contribute equally towards their production. 
IFN-γ produced by NK cells are detectable within 6 h of co culture with 
infected RBC, their numbers peaking at 24 h in most donors. There is 
marked differences between donors in magnitude of the NK-IFN-γ 
response. This difference between donors suggests a variation in their 
ability to mount a rapid proinflammatory cytokine response to malaria 
infection that may, in turn, influence their innate susceptibility to malaria 
infection and its complications (40). Peripheral blood mononuclear cells 
taken from African children presenting with uncomplicated malaria 
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disease were more efficient producers of IFN-γ when stimulated with 
sporozoite or merozoite antigen peptides in contrast to cells taken from 
children with severe malaria (41). Furthermore, hyperparasitemia was 
associated with a lower frequency of producing CD4+Tcells in Gabonese 
patients presenting with acute P. Falciparum malaria (42).  
In murine model, enhanced NK cell activity were detected in spleens of 
mice infected with irradiated Plasmodium berghei sporozoites was 
detected (43). More recently, Plasmodium yoelii sporozoite infection has 
been shown to induce a rapid inflammatory response in the liver 
characterized by NK cell, macrophage, and T cell infiltration and IFN-γ 
production (44). It has been proposed that protective immunity to P. yoelii 
liver stages mediated by parasite-specific CD8+ T cells is dependent on 
the presence of IL-12 and NK cells (45), indicating an important synergy 
between innate and adaptive immunity in this system. Innate immunity 
may have a role in immunity against blood stages malaria as depletion of 
NK cells from Plasmodium chabaudi-infected mice results in a more 
severe course of infection with higher parasitemia and increased mortality 
(46).  
Studies in both mice and humans have shown that proinflammatory 
cytokines, specifically IL-12, IFN-γ and TNF-α, are essential mediators of 
protective immunity to erythrocytic malaria (47, 48).  Resistance to 
rodent malaria is found to be dependent on signals mediated by IFN-γ 
(47), and the difference between lethal and nonlethal infections depends 
on the ability of the mouse to generate an early IL-12, IFN-γ or TNF-α 
response (48, 49, 50, 51). TNF-α and IFN-γ act synergistically to 
optimize nitric oxide (NO) production (52), which in turn leads to 
parasite killing (53). In humans, IFN-γ production is correlated with 
resistance to reinfection with Plasmodium falciparum (54, 55) and 
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protection from clinical attacks of malaria(56), plasma TNF-α and nitric 
oxide levels are associated with resolution of fever and parasite clearance 
(57, 58), and plasma TNF-α and IFN-γ mediate loss of infectivity of 
circulating gametocytes (59). Many vaccine developers now regard IFN-γ 
production to be the hallmark of effector T cell function for malaria (60, 
61). 
The role of nitric oxide in malaria:  
NO is formed by the oxidative deamination of the amino acid L-arginine 
by nitric oxide synthases (NOS). Three isoforms of this enzyme have 
been described, Neuronal NOS (nNOS or NOS1). NO is naturally found 
in both the central and peripheral neuronal cells, where NO is 
neurotransmitter. Endothelial NOS (eNOS or NOS3) is expressed by the 
endothelium and other cell types and is involved in cardiovascular 
homeostasis. In contrast, inducible NOS (iNOS or NOS2) is not found in 
resting cells, but its gene is rapidly expressed in response to stimuli such 
as proinflammatory cytokines. When induced, iNOS synthesizes 100-
1000 times more NO than the constitutive enzymes and for prolonged 
periods. This high concentration of NO may inhibit many microbes, but 
may also damage the host, thereby contributing to pathology. NO inhibits 
the growth of many bacteria and parasites in vitro. The antimicrobial 
effect is not from NO itself, but from reactive nitrogen intermediates 
formed by the oxidation of NO. For example, reaction between NO and 
the free radical superoxide (O2 ) results in the formation of the unstable 
molecule peroxynitrite (OONO ). These reactive nitrogen intermediates 
inactivate key microbial enzymes, such as ribonucleotide reductase and 
aconitase, by reacting with iron containing groups in these enzymes. 
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Nitric oxide has been shown to be protective against Plasmodium 
falciparum in vitro. NO levels were inversely related to disease severity, 
with levels highest in subclinical infection and lowest in fatal cerebral 
malaria (62). NO appears central to the host response in malaria, 
mediating the antiparasitic effects of proinflammatory cytokines at each 
stage of the parasite life cycle in both experimental and possibly human 
infection (63). In addition to its protective role, NO have been suggested 
as a mediator in cerebral malaria. NO production requires tight control to 
limit cytotoxic damage to the host's own cells. Unregulated production 
may lead to a variety of damaging effects including alterations to normal 
neurological functions during cerebral malaria (64). 
 
CSF NO  intermediates (nitrite, nitrate), which may be more reflective of 
local cerebral production and is less affected by diet and other 
confounders, is increased in cerebral malaria(65). Immunohistological 
studies suggest widespread iNOS induction in cerebral endothelium and 
resultant NO production. Different genetic polymorphisms of the iNOS 
promoter region have been associated with increased risk of death from 
cerebral malaria in Gambian children(66) and with protection from severe 
malaria in Gabonese children(67) suggesting that complex genetic factors 
may determine iNOS production and thereby influence clinical outcome. 
 
Adaptive immune response: 
Both the cellular and humoral arms of the adaptive immune system are 
important elements in the eradication of Plasmodium from the body, and 
both are dependent on αβ CD4+ lymphocytes. Both Th1 and Th2 
responses are required in controlling of the infection, but they need to be 
adequately tuned in intensity and time (68, 69). Both Th1 and Th2 are 
activated during infection with P. yoelii in mice, but early activation of 
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Th2 cells leads to increased susceptibility to infection (70). In addition, in 
P. chabaudi chabaudi AS infection there is a shift from Th1 to Th2 
during peak parasitemia that is important for clearance of parasites (71).  
Treatment with anti-TNF-α monoclonal antibody results in a tendency 
toward longer times for parasite clearance. Interestingly, this effect is 
associated with reduced levels of IFN-γ (72).  
IL-18 was found to enhance Th1 immune responses through IL-12 and 
also by potentiation of Th2 immune responses in the absence of IL-12. In 
malaria, the role of IL-18 in early immunity against the parasite has 
recently been suggested that as protective by enhancing IFN-γ production 
in vivo (73). 
Early IL-10 production has been associated with susceptibility to 
infection (69, 74), and it is thought that this cytokine has a prominent anti-
inflammatory effect, limiting in some way the damage which occurred on 
normal tissues by an excessive Th1 response.  
Studies with transforming growth factor β (TGF-β), another anti-
inflammatory cytokine, resulted in contradictory findings. On the one 
hand, positive effects of TGF-β on immune responses against 
Plasmodium have been described. Anti-TGF-β worsened P. berghei 
infection and conferred susceptibility to P. chabaudi but not to P. yoelii 
(75). On the other hand, resistant mice became susceptible to P. chabaudi 
upon administration of recombinant TGF-β, whereas susceptible mice 
became resistant upon administration of anti-TGF-β, with concomitant 
increases in IFN-γ and NO production (76) 
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Cytokines in the immunopathology of malaria 
The pathogenesis of malaria is multifactorial and most probably involves 
immunologic and nonimmunologic mechanisms (77).  The parasite itself 
can contribute to the severity of disease, as it has an ability to infect a high 
percentage of erythrocytes (78) and to induce production of 
proinflammatory cytokines. Glycosylphosphatidylinositol toxin from 
Plasmodium is an important pathogenic factor due to its ability to induce 
TNF-α and IL-1 (79).  
Severe malaria has been associated with high circulating levels of 
inflammatory cytokines such as TNF-α, IL-1 and IL-6.  TNF-α is higher 
in plasma from children with CM or severe anaemia than in plasma from 
UM malaria cases (80-82). IFN-γ has been linked to the onset of 
pathology in mice as well as in humans. The detrimental effects of IFN-γ 
are believed to be due to its ability to activate macrophages which, in 
turn, produce endogenous pyrogens (TNF-α, IL-1and IL-6) leading to an 
inflammatory cascade (83, 84). IFN-γ is essential for the onset of CM as 
IFN-γ receptor deficient mice do not develop CM (85). 
 
Other example of the role of cytokines in pathogenesis of severe malaria 
is in severe anaemia. The levels of IL-12, a cytokine that boosts 
erythropoiesis, are correlated with anaemia (86). Furthermore, 
administration of recombinant IL-12 is able to ameliorate anaemia in 
mice infected with P. chabaudi (87). Recently, production of macrophage 
inhibitory factor, another factor produced by macrophages, has been 
correlated with the development of anaemia in mice (88). Higher levels of 
TNF-α in serum were found to be associated with severe anaemia (89). 
However, this is not a universal finding. In another study, low levels of 
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this cytokine were detected in the serum of Ghanaian children with severe 
anaemia (90).  
This may be   explained by the fact that cytokine balance is found to 
predict malaria clinical presentation. IL-10 was found to be low in severe 
anaemia and TNF-α: IL-10 ratio was higher in children with severe 
anaemia than in other malaria complication (82, 91). So, 
antiinflammatory cytokines are required to down regulate the 
pathological effects of high concentrations of the proinflammatory 
cytokines. 
Serious complications of malaria 
The following pages will present the more serious common complications 
of severe malaria and the present knowledge of their pathophysiology.  
Cerebral malaria 
Cerebral malaria is a leading cause of death in severe malaria. Malaria 
affects the brain in two ways; either direct brain involvement or indirect 
through high grade fever, hypoglycemia, hyponatremia and severe 
anemia leading to various neurological manifestations. World health 
organization (WHO) defined cerebral malaria as an arousable coma for 
more than thirty minutes in patients with positive blood film for malaria. 
The coma is usually preceded by fever and convulsions (92). These 
convulsions can be generalized tonic- clonic or focal and are associated 
with poor outcome (92, 93). Most children survive with appropriate 
management but about 10.9% recover with neurological and cognitive 
impairments (92, 94, 95, 96). Deaths occur within the first day of 
admission (92).    
Gross examination of the brain of patients who died of CM revealed 
edematous swollen brain with petechial and subarachnoid hemorrhages. 
Microscopically, there is damage of the vessel walls and blood brain 
 24
barrier disruption, enlarged perivascular spaces and adherence of 
leucocytes and parasitized RBCs to brain vessels. Scanning electron 
microscopy of these patients revealed the same feature and the adhered 
leucocytes are monocytes and lymphocytes (97) 
The pathogenesis of cerebral malaria is still not well known. Magnetic 
resonance study of experimental CM suggests inflammatory, ischemic 
process and edema role in fatal CM. Vascular damage and blood brain 
barrier disruption are the cause of hemorrhages and edema which 
contribute to reduction in the brain perfusion and ischemia. Reduced high 
energy phosphate and high brain lactate together with edema which 
worsens the ischemia by further compressing the arteries was reported 
(98). Another study revealed metabolic changes in CM consistent with 
brain ischemia rather than hypoxia (99). Increased vascular permeability 
and subtle changes in BBB integrity were reported in CM (100, 101, 
102). Other mechanisms of the reduction of the blood flow involve 
endothelin. Endothelin is a 21 peptide synthesized by the endothelial and 
others cells. Its expression is augmented by stressful stimuli to the 
endothelium. It is a potent vasoconstrictor. In CM where endothelium is 
damaged, it provides a stimulus to increased expression of endothelin 
which in turn induces brain vessels constriction leading to ischemia and 
neuronal damage (103). All these finding support ischemia and the 
inflammatory process as the cause of CM.  
Other studies attribute CM pathogenesis to sequestered lymphocytes and 
parasitized RBCs leading to cerebral hypoxia. An ultra structural study of 
the brain carried on Thialand and Vietnam on 65 patients who died of 
severe malaria revealed higher level of sequestration of parasitized RBCs  
in the brain vessels of patients with CM compared with those without CM 
and the degree of sequestration in the brain vessels is positively 
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correlated with premortem coma (104). Depletion of alpha and beta 
lymphocytes protects against CM (102). Lymphocytes induce local 
production of IFN-γ, TNF-α and NO which are known to have a 
pathological role in CM (105). Depletion of T regulatory cells in mice 
was found also to protect it from CM. The mice had reduced numbers of 
active CD4 and CD8 T cells in the spleen and lymph nodes with selective 
reduction of CD8 T cells in the brain suggesting T regulatory cells 
contribution to pathogenesis of CM by modulating the immune response 
(105). Platelets were found to accumulate in brain vessels of patients 
dying of CM and may play a role by providing adhesion receptors 
involved in sequestration (107).  
The sequestration of parasitized RBCs and WBCs in the brain vasculature 
result in obstruction of the blood flow and hypoxia leading to neuronal 
dysfunction as apparent from degeneration of the neurons and high CSF 
lactate (108).  
Sequestration is a mechanism of protection for the parasite to escape from 
phagocytic activity of the spleen and provide good media for parasite 
growth as sequestration occur in capillaries and venules (109). 
Sequestration of parasitized RBCs involves adhesion between the 
parasitized RBCs and the vascular endothelium (110, 111). At the time of 
entry of merozoite to the RBC, it inserts antigens on the RBC surface 
membrane. These antigens appear as irregularities or protrusions in the 
RBCs surface membrane and are known as knobs. There are three 
proteins involve in the knobs; histidine-rich protein (PFHRP-1) and 
plasmodium falciparum erythrocyte membrane protein-1 and -2 (PFEMP-
1, PFEMP-2) (112, 113, 114). Through these knobs the parasitized cells 
adhere to the endothelial receptors (platelet glycoprotein-IV, intercellular 
adhesion molecules-1(ICAM-1), vascular cell adhesion molecules-
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1(VCAM-1), thrombospondin, E-selectin and chondroitin sulphate (115, 
116, 117, 118). Some of these endothelial receptors are constitutively 
present; some are enhanced by cytokines while others are induced by 
cytokines. Platelet glycoprotein-1V (CD36) is found on platelet, 
endothelial cells, monocyte and erythroblast. ICAM-1 molecules are 
present in most capillaries endothelium however its expression was found 
to be upregulated by TNF, IFN and IL-1 during CM (119). TNF, IL-1 and 
IL-4 induced E-selectin and VCAM-1 expression in the vascular 
endothelium and are not constitutively expressed on the vascular 
endothelium (120). Chondroitin sulphate is a recently discovered 
adhesion molecules involved in the sequestration of the parasite in the 
placenta (118). 
Ninety percent of adhesion of the parasitized RBCs to the endothelium 
involves CD36 and ten percent to ICAM-1 while adhesion to the other 
adhesion molecules is minimal (121). The adhesion process occurs in 
three steps; tethering, rolling then firm attachment (122). Some of the 
adhesion molecules facilitate the process of adhesion of the parasitized 
RBCs to other adhesion molecules eg ICAM-1 facilitates adhesion to 
CD36 (122). Still the binding to CD36 can occur directly (124). Some of 
the endothelial receptors are constitutively expressed and show no 
increase in severe disease while others are induced during the course of 
the disease and showed to be high in patients with CM (125). 
Increased RBCs rosetting and decreased deformability of the RBCs were 
reported as contributing factors in obstruction of the cerebral blood 
vessels.  Rosetting is a mechanism by which parasitized RBCs adhere to 
non-parasitized RBCs. Increased rosette formation was detected in 
patients with CM (126) and the sera of those patients are deficient of anti-
rosetting antibody (127). Decreased deformability of parasitized RBCs 
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was found to be a strong indicator of unfavorable prognoses in severe 
malaria (128). 
The other supposed mechanism of CM pathogenesis involves cytokines. 
Early production of cytokines was found to be protective against CM but 
late production is associated with increased risk of getting CM. In mice, 
infection with plasmodium berghei ANKA results in production of IFN-γ 
at 4 day postinoculation and CM on day 6, while infection with P. berghei 
K173 is associated with production of IFN-γ, IL-10 and IL-12  24 h 
postinoculation but does not result in CM. When mice were co-infected 
with both ANKA and K173, they produced an early cytokine response, 
including a burst of IFN-γ at 24 h post inoculation. These co- infected 
mice failed to develop CM (129). 
TNF-α is a key cytokine in the pathogenesis of CM as high serum 
concentration of TNF-α and its two soluble receptors STNF R1, R2 were 
detected in patients with CM (130). Augmented expression of TNF-α and 
IFN-γ were also found in the brains of patients with CM (131, 132). 
Consistent with these findings, experimental and clinical studies revealed 
that serum TNF-α level is high at the onset of neurological signs and that 
passive immunity against TNF-α significantly increased mouse survival 
rate and prevented the histopathological changes which characterize CM 
and the appearance of the neurological signs (133). Clinical data obtained 
from African children with CM showed elevated levels of TNF-α are 
associated with severe neurological involvement and fatal outcomes (81). 
TNF-α was thought to cause CM through many mechanisms. TNF-α 
upregulales the expression of the adhesion molecules involved in 
sequestration (119, 133). It is responsible for many of the histological 
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features associated with CM in mice like degeneratrion, oedema and 
haemorrhages (133) 
 
TNF-α was also found to induce NO production in the brain during CM 
(134). NO is known to affect synaptic transmission and thus it may 
contributes to the seizure and coma (135). Increased expression of 
inducible NO synthase was detected in the neurons, microglial cells, 
astrocytes and in the macrophages surrounding ring hemorrhages. Its 
expression is decreased in the recover CM and there is positive 
correlation between the intensity and the number of iNOS positive vessels 
and severity of malaria related histopathological changes (135). NO 
metabolites were found to be higher in plasma and the CSF of children 
with CM and associated with poor outcome (137, 65, 138).  
 
Microglial cells activated by TNF-α were found to undergo 
morphological changes during CM like soma enlargement, retraction of 
the ramified process, increased amoeboid appearance and vacuolation 
which are consistent with microglial cells activation. The activated 
microglial cells redistribute toward vessels (139, 140). Microglial cells 
are thought to cause CM pathology through excitotoxic mechanism as 
increased quinolonic acid concentration was found to be high in the CSF 
of patients with CM and associated with increased severity of the disease 
(141). 
 
IFN-γ contributed to CM pathogenesis through augmentation of both the 
production and the action of TNF-α. Monoclonal antibodies against IFN-
γ prevent the occurrence of CM as well as preventing elevation of TNF-α 
(142). In addition to its ability to up-regulate TNF-α production, IFN-γ 
also promotes the quinolinic acid pathway of tryptophan metabolism by 
inducing the enzyme indoleamine 2, 3 dioxygenase. Quinolinic acid is a 
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neurotoxic may also contribute to the development of CM. Indoleamine 
2,3 dioxygenase activity has been reported to be 5 fold higher in mice 
with cerebral malaria than in those without cerebral symptoms and 
associated with a marked increase in the Quinolinic: kyurenic acid ratio 
(143). Raised Quinolinic: kyurenic acid ratio was reported in Vietnamese 
adults with cerebral malaria with especially high ratio in those who died 
(144). 
On the other hand, IL-10 is protective against CM development by 
inhibiting TNF-α as IL-10 knockout mice infected with plasmodium 
chabaudi develop greater parasitic sequestration and severe cerebral 
edema and hemorrhages and administration of anti-TNF-α ameliorate 
both cerebral edema and haemorrhages (145).   
In contraversery, anti TNF-α antibody did not affect the outcome of 
children with CM in some studies (146). NO metabolites were low in 
both the plasma and the CSF of children with CM (141, 147). NO is 
thought to has a protective role in CM by inhibiting brain indoleamine 2/3 
dioxygenase induction and quinolinic acid accumulation during hypoxia 
(148). 
Repeated convulsions 
WHO defines repeated convulsions as convulsions more than 2 within 24 
hours despite cooling. It is the most prevalent complication in young 
children (149).  
Repeated convulsions were found to indicate cerebral dysfunction rather 
than being febrile convulsions as no correlation between body 
temperature and convulsions was detected.  It may be the early warning 
signs of cerebral involvement (150). 
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An increased prevalence of epilepsy was reported in children previously 
admitted with CM and repeated convulsions compared with the 
unexposed group. The most commonly encountered seizure types were 
tonic–clonic, focal becoming secondarily generalized and both. Twenty-
six percent of children who developed epilepsy had EEG abnormalities at 
time of severe malaria. The prevalence of epilepsy associated with 
malarial repeated convulsions is more than twice that reported after 
complicated febrile seizures (151). 
Severe anaemia 
Severe anemia is one of the major manifestations of severe malaria. 
WHO defines severe anemia as hemoglobin level below 5g/dl. It is 
usually normocytic normoochromic anaemia. In children, it is commonly 
encountered below 5 years of age (9).  
 
Severe anaemia was found to contribute by 53% of malaria related deaths 
in study carried in Kenya (151) while some studies revealed that severe 
anaemia mortality rate increased only when it is combined with other 
malaria complications like cerebral malaria and respiratory distress; but it 
is not a predictor of fatal outcome if it is the only presentation (153). 
 
The pathophysiology of severe anaemia is complex and multifactorial. 
Malarial anaemia is thought to arise from both decreased red blood cell 
(RBC) production and increased RBC destruction (31). Destruction of 
RBCs can occur as a result of parasite invasion and replications. The 
parasite lives in red blood cells, use haemoglobin for their growth and 
replication and at the end schizonts rupture and destroy their erythrocyte 
host cells, although some parasites may be removed from erythrocytes as 
immature ring forms by phagocytic cells (154). Anaemia correlates with 
the degree of parasitemia and duration of the acute illness (155, 156). The 
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deformability of the RBCs is reduced in severe malaria and provides 
another signal for clearance of RBCs by spleen (157).  
  
Infected erythrocytes may also be phagocytosed by macrophages 
following opsonization by immunoglobulins and/or complement 
components (158, 159, 160). Circulating immune complexes were 
detected in malaria which leads to activation of the complement system 
inducing removal of the RBCs through phagocytosis in the liver and the 
spleen (158). Complement system activation resulting from binding of 
IgG to plasmodium falciparum erythrocyte membrane protein-1(PFEMP-
1) is reported (158, 161, 162). Furthermore children with severe malarial 
anemia were found to have reduced levels of complement regulatory 
proteins (complement receptor1, decay accelerating factor and membrane 
inhibitor of reactive lysis) leading to increased susceptibility of RBCs to 
complement deposition (159).  
   
Destruction of the RBCs is not confined to the infected ones but 
uninfected RBCs are also destroyed by the immune system and it may be 
the major cause of haemoglobin loss (163). Immunoglobulin was found 
to bind uninfected RBCs enhancing their phagocytosis(164). Ring surface 
protein (RSP) is a parasite derived protein inserted on the surface of the 
RBCs in which the parasite fails to invade. Anti- RSP antibodies were 
detected in the serum of patients with severe anaemia and were found to 
enhance phagocytosis and destruction of this RSP- bound RBCs (165). 
Furthermore, this antigen was detected in RBCs precursors in the bone 
marrow leading to its destruction by complement mediated phagocytosis 
(165). Uninfected RBCs were also found deficient in complement 
regulatory protein leading to activation of complement system (160). 
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Sometimes in asymptomatic malaria, anaemia is frequently out of 
proportion to the low level of parasitaemia found (167), suggesting that it 
is not mediated simply by direct haemolysis of parasitized red blood cells. 
Reticulocytopenia has been observed in numerous clinical studies of 
malarial anaemia (168, 169). Suppression of erythropoeisis and 
dyserythropoeisis are reported in malaria (168). The histopathological 
study of the bone marrow of children with malarial anaemia shows 
impaired bone marrow response ( 170, 171, 172), erythroid hyperplasia, 
with dyserythropoiesis, cytoplasmic and nuclear bridging and irregular 
nuclear outline(168). 
 
Parasite factors, nonoptimal response to erythropoietin and 
proinflammatory cytokines may affect bone marrow function and 
contribute to the development of severe anaemia in malaria. Hemozoin, a 
product of heme digestion by the parasite, is supposed to inhibit 
erythropoeisis in malaria. In children with malarial anaemia, the 
proportion of circulating monocytes containing hemozoin is found to be 
associated with anaemia, and this is independent of the level of 
circulating cytokines, including TNF-α (173). Histological examination 
of the bone marrow of children who died from malaria showed that 
pigmented erythroid and myeloid precursors are associated with the 
degree of abnormal erythroid development (173). Another way by which 
hemozoin inhibits erythropoeisis is through induction of NO production 
(174). NO was found to suppress erythropoiesis (175) and to induce 
apoptosis in erythropoietic precursors (176). 
 
Erythropoietin, a hormone produced by the kidney and the liver, 
stimulates RBCs production. In malaria, erythropoietin level is 
appropriate to degree of anaemia but the response of the bone marrow is 
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limited as apparent from inadequate reticulocytosis. There is suboptimal 
proliferation of erythroid progenitor cells leading to suboptimal number 
of erythroblast. Also the maturation and differentiation of this 
erythroblast is suppressed (177, 178). 
 
There are controversial findings regarding the role of TNF-α, IL-10 and 
IFN-γ in pathogenesis of severe anaemia in children. TNF-α inhibits all 
stages of erythropoiesis (179) and IFN-γ works with TNF-α to inhibit 
erythroid growth and differentiation by up-regulating expression of 
TRAIL, TWEAK, and CD95L in developing erythroblasts (180). In 
children with severe anaemia, TNF-α was found to be high while IL-10 
was low (181, 182, 183). However, in a nonlethal P chabaudi infection of 
mice, neutralization of TNF-α or IFN-γ has no effect on in vitro 
erythropoiesis (184).  The severity of anaemia seems to be dependent on 
levels of TNF-α relative to its regulator, the potent anti-inflammatory 
cytokine IL-10. Several clinical studies have demonstrated that a low ratio 
of plasma IL-10/TNF-α is associated with severe malaria anaemia in 
young children (82, 91). IL-10 knock-out mice infected with P 
chabaudi display increased anaemia (184) which was reversed following 
TNF-α neutralization in vivo (186). Thus IL-10 may protect against the 
bone marrow suppression and the erythrophagocytic activity induced by 
TNF-α.   
 
Some studied, however, reported that IFN-γ is potential marker of 
protective immunity against severe anaemia in malaria. A study 
conducted in Kenyan children aimed to assess IFN-γ  responses to six 
preerythrocytic antigens detected that IFN-γ positive responders had 
higher haemoglobin levels and significantly reduced prevalence of severe 
anaemia compared with IFN-γ nonresponders, suggesting that IFN-γ 
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immune responses to these preerythrocytic antigens were associated with 
protection against malarial anaemia (187).  
 
Anaemia in falciparum malaria is clearly multifactorial and there is a 
strong argument that erythrocyte destruction and ineffective 
erythropoiesis play equal parts in the etiology of malarial anaemia. 
 
Hypoglycemia 
WHO defines hypoglycemia as blood glucose level below 40mg/dl. 
Hypoglycemia is found to be associated with increased morbidity and 
mortality in malaria (188, 189). It is common in children less than five 
years of age (190, 191). 
  
The pathophysiology of hypoglycemia in malaria is not well understood 
probably it is a multifactorial. Glucose consumption by the parasites, 
hyperinsulinemia, gluconeogensis insufficiency and cytokines were all 
supposed to play a role. 
The malaria parasite exhibits a rapid growth and multiplication rate 
during many stages of its life cycle. This necessitates that the parasite 
acquires nutrients and metabolize these various biological molecules in 
order to survive and reproduce. The parasite depends on glucose as a 
primary source of energy and it take it from host blood stream (192). 
Woodrow et al (1999) discovered a parasite-encoded hexose transporter 
that is localized to the region of the parasite plasma membrane within the 
infected red cell. It is a facilitative transporter with relatively high affinity 
for glucose. This transporter is presumed to act in conjunction with 
important changes in the permeability properties of the infected 
erythrocyte membrane to regulate the uptake of substrates by parasites 
(193). The parasite exhibits a high rate of glycolysis and utilizes up to 75 
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times more glucose than uninfected erythrocytes. Most of the glucose is 
converted to lactate and the high lactate dehydrogenase (LDH) activity is 
believed to function in the regeneration of NAD+ from NADH which is 
produced earlier in the glycolytic pathway by glyceraldehyde-3-phophate 
dehydrogenase and about 85% of glucose is converted to lactate which is 
exported from the infected cells (194). 
Some studies detected hyperinsulinemia at times of hypoglycemia and 
reporting that hyperinsulinemia may be the cause of low blood glucose 
levels (195, 196). Elased et al (1994) reported that administration of 
diazoxide, an insulin secretion inhibitor, prevents development of 
hypoglycemia (195). Parasite derived factors and quinine treatment were 
found to stimulate insulin secretion (195, 196, 197, 198, 199). However, 
another study reported appropriated insulin response in children with 
hypoglycemia (189, 191) 
 
Gluconeogenesis insufficiency is also reported to play a role in 
hypoglycemia pathogenesis. English et al (2008) investigated the 
potential importance of glycerol as a substrate for gluconeogenesis and 
whether substrate limitation contributes to hypoglycaemia in severe 
malaria in African children. About 16% were hypoglycaemic on 
admission, while at least 9% of children with severe malaria treated with 
quinine and a concurrent 4% dextrose infusion had a definite episode of 
hypoglycaemia after admission. Blood levels of gluconeogenic precursors 
(alanine, glycerol and lactate) levels were high in those with either 
hypoglycaemia on or after admission as they are in children not having an 
episode of hypoglycaemia. However children with severe malaria with 
hypoglycaemia at some stage are more acidotic and suffered from renal 
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impairment than those who are not hypoglycaemic. The study 
concluded that gluconeogenesis is impaired in severe malaria (197). 
 
Taylor et al (1989) assessed the importance of both pretreatment and 
quinine-related hypoglycemia in children in an area in which the disease 
is endemic in 95 Malawian children with falciparum malaria and altered 
consciousness who were treated with intravenous quinine. Hypoglycemia 
was associated with low plasma insulin concentrations and with elevated 
plasma concentrations of lactate, alanine, and 5'-nucleotidase which 
suggests impaired hepatic gluconeogenesis (189).  
In contrary to the English and Taylor studies, a study carried by Dekker et 
al aimed to measure basal glucose production and gluconeogenesis and 
estimate  the flux of the gluconeogenic precursors in Kenyan children 
with uncomplicated falciparum malaria before and during infusion of 
alanine. Alanine infusion increased basal plasma glucose concentration 
suggesting that glucose production in children with uncomplicated 
falciparum malaria is potentially limited by insufficient precursor supply 
leading to failure to compensate in the presence of decreased glycogen 
flux to glucose, increasing the risk of hypoglycemia (191). 
The role of cytokines in pathogenesis of hypoglycemia is controversial. 
TNF-α is believed to increase rather than decrease blood glucose level 
(195). TNF-α was found to inhibit insulin secretion and increased 
peripheral resistance to insulin (24, 25, 195) leading to increased blood 
glucose level. On the other hand some studies detected high TNF-α, IL-
10 and IL-6 levels to be associated with hypoglycemia (191, 196, 200). 
 
Metz et al (1999) conducted a study in six healthy subjects to evaluate the 
endocrine and metabolic effect of IFN-γ. He detected that administration 
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of IFN-γ increased plasma concentration of ACTH and cortisol but 
plasma glucose was not altered indicating that IFN-γ is a minor stimulator 
of endocrine and metabolic pathways (201). However the study did not 
rule out the effect of IFN-γ in endocrine and metabolic pathways during 
infection. Some studies revealed that IFN-γ reduced the development of 
the exoerythrocytic parasite stage and the developing parasitemia which 
was associated with hypoglycemia (202, 203). 
 
Renal involvement in malaria  
 Renal involvement occurs in both UM and severe malaria. A study 
carried in Tamale, northern Ghana revealed sub clinical impairment of 
renal function in 17% of children with UM.  Eighty five percent of them 
had protienuria of either glomerular or tubular pattern indicating that 
glomerulonephritis and tubular damage can occur in UM (204). 
 
Renal involvement commonly comes in combination with other malaria 
complication. Children with CM had higher rate of developing acute 
renal failure and it was usually severe in comparison with children with 
UM (205). A study Carried in Gambia compared renal function in terms 
of serum creatinine, pronteinuria and creatinine clearance in patients with 
cerebral malaria, UM and other febrile illnesses. It revealed that children 
with CM had higher serum creatinine and higher levels of proteinuria 
than the other two groups. Children with UM had higher serum creatinine 
and higher levels of proteinuria than the other febrile illnesses group 
(206).  
Renal involvement in malaria presents as acute renal failure, 
tubulointerstitial nephritis or as nephrotic syndrome. Plasmodium 
falciparum and plasmodium vivax are responsible for 80.9% and 11.7% 
of cases of acute renal failure respectively detected by a study conducted 
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in Banaras Hindu University, India during the period 1995-1999 (206). 
Children were oliguric or anuric in most of the cases, 62% recovered 
completely and about 18.5% died. Age, oliguria, central nervous system 
involvement, disseminated intravascular coagulation and multiorgan 
failure were detected as bad prognostic factors in renal failure due to 
malaria (207, 208). 
 
Histopathologically, the kidney shows tubular degeneration, endothelial 
cell swelling and cytoplasic vacuolation. Mononuclear cell with malaria 
pigment granules in their cytoplasm and sequestration of parasitized 
RBCs were seen in the glomerular capillaries (209). 
 
Pathogenesis of acute renal failure is multifactorial. In one study 
hypovolemia was found to be the dominant cause of cases while 
hyperbilirubinemia, intravascular haemolysis and sepsis were the other 
causes (207). Sequestration of parasitized red blood cells in the renal 
vasculature leads to obstruction of the flow and renal ischemia which can 
result in acute renal failure (209). Rare complication of Plasmodium 
falciparum infection, myositis, through rhabdomyolysis and myglobinuria 
was reported to cause acute renal failure (210).  
 
Tubulointerstitial nephritis can present as proteinuria or even acute renal 
failure. Kidney tubular cells express TNF-α gene and release this 
cytokine upon stimulation by lipopolysaccharide (211).  Thus, the tubular 
cells have a capacity to modulate immune response within the kidney 
during inflammation. A study carried on mice attribute pathogenesis of 
tubulointerstitial nephritis to cytokines dysregulation. High serum TNF- α 
and IL-10 were reported together with increased expression of TNF-α, 
IL-1 and IL-6 in both the tubules and the walls of the arteries in the 
interstitium. There is positive correlation between antibody staining for 
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TNF-α and IL-1 in the tubules and the level of proteinuria. IL-10 staining 
was found in normal tubules and arteries. There was inverse correlation 
between staining for IL-10, TNF-α, IL-1 and the degree of proteinuria. 
These findings implicate TNF-α as a cause of tubular damage which 
might be due to direct cytotoxic mechanism or through an autoimmune 
mechanism. IL-10 was thought to be protective as it was only found in 
normal tubules (212). 
Electrolyte changes  
Electrolyte changes are common in malaria. Hyponatremia and 
hyperkalaemia were encountered on admission while hypokalaemia, 
hypomagnesemia and hypocalcaemia were detected one day after 
admission after correction of acidosis (213). 
 
Hypokalaemia & hyperkalaemia: Acidosis is a recognized 
complication of the severe malaria and a predictor of fatal outcome (214, 
215). Alterations in plasma potassium concentrations are commonly 
associated with acidosis (213). There is little information about the 
changes in potassium in severe malaria. A prospective study examining 
the changes in plasma potassium in the first 24 hrs following admission in 
children with severe malaria presented with impaired consciousness or 
deep breathing and acidosis, detected that on admission, serum potassium 
was normal (3.0-5.5 mmol/L) in 81.6%, low (<3 mmol/L) in 11% and 
high (5.5mmol/L) in 6.3% of children. Plasma potassium decreased 
rapidly within 4-8 hrs of admission where 40% of patients became 
hypokalemic after correction of hypovolemia by normal saline infusion. 
Fractional excretion of potassium and the transtubular gradient of 
potassium were above the normal range, indicating renal potassium loss. 
So on correction of acidosis, plasma potassium decreases precipitously 
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and thus careful, serial monitoring of serum potassium is suggested in 
patients with severe malaria complicated by acidosis (216). 
 
Hyperkalaemia may complicate severe malaria and it is associated with 
increased mortality. Maitland et al (2005) conducted a study in Kenyan 
children detected that at admission to the hospital, hyperkalaemia 
complicated 16% of cases of acidosis due to severe malaria of whom 78% 
died soon after admission. After admission, mild asymptomatic 
deficiencies in magnesium and phosphate levels were common but were 
not associated with any deleterious effect. Asymptomatic potassium 
deficiency developed despite provision of this electrolyte at maintenance 
doses (213). These cases were hypoglycemic. Presumably potassium 
entry with glucose had led to hypokalaemia.  
Hyponatremia: Hyponatremia is common in African children with 
severe malaria, but the cause is unknown. ADH has a controversial role in 
hyponatremia pathophysiology. ADH secretion is found to be 
inappropriate in some studies (217, 218) and appropriate to the degree of 
dehydration in others (219). Sowunmi et al (2000) measured plasma 
sodium and arginine vasopressin concentrations in 30 children with 
severe malaria detected hyponatraemia in 53% of the children and was 
unrelated to peripheral parasite density, dehydration or abnormal 
renal function. In 67% of children with hyponatraemia plasma ADH 
levels were inappropriate indicating that ADH secretion is common in 
children with severe malaria and may influence fluid therapy after 
correction of initial dehydration (217). Similar finding was reported by 
Holst et al (1994) (218) 
However, Hanson et al (2009) showed that hyponatremia in severe 
malaria is not caused by inappropriate ADH secretion but reflected 
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hypotonic fluid intake. The study involved 171 Bangladeshi adults with 
severe malaria. On admission, 57% of patients were hyponatremic. 
Plasma ADH hormone concentrations were similar in hyponatremic and 
normonatremic patients and mortality was lower in hyponatremic 
than normonatremic patients. Plasma sodium normalized with crystalloid 
rehydration form indicating that the hyponatremia was due to continued 
oral hypotonic fluid intake in the setting of hypovolemia and requires no 
therapy beyond rehydration (219). Whether these findings can be 
extrapolated to children remains uncertain. 
Renal impairment during infection is found to result in sodium loss. 
Renal function was assessed in 40 children during the acute illness and 
after recovery from falciparum malaria. Creatinine clearance was 
significantly lower during the acute illness than after recovery. 
Hyponatraemia occurred in 12.5% during the acute phase and fractional 
sodium excretion was raised in 27% during the acute illness and 
continuing sodium wastage occurred in 17% after recovery (220).  
 
Cerebral salt wasting syndrome is another reported mechanism of 
hyponatremia which occurs in cerebral malaria. In a prospective study, 
hyponatraemia was observed in 52.6% of children with cerebral malaria 
on admission and 10% developed hyponatraemia between 48 and 96 hrs 
after admission. In half of cases, there was continuing urinary sodium 
loss. An increase in plasma sodium in the first 24 hours of admission was 
associated with a reduction in seizure frequency during this period as 
compared to the reported 24 hour of pre-admission seizure frequency 
(221) 
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Heamoglobinuria 
Haemoglobinuria is a severe malaria complication known to occur in 
long-term residents in Plasmodium falciparum endemic areas who take 
quinine irregularly and in European expatriates. Rogier et al (2003) 
conducted a prospective study involved the whole population of a 
Deilmo, a village in Senegal detected three cases of haemoglobinuria in 
children who had malaria every 4-6 weeks over many years and 
repeatedly received quinine (222). This complication became less 
frequent when chloroquine was the drug of choice for malaria from 1950 
until the 1990s (223). As P. falciparum resistance to chloroquine 
developed, quinine was increasingly used in clinical practice for treating 
malaria infections. Haemoglobinuria seemed to reappear at the end of the 
1990s (224-225).  Glucose-6-phosphate dehydrogenase (G6PD) 
deficiency was also frequently associated with the syndrome (226).  
Other antimalarials are also found to be associated with haemoglobinuria. 
Brunnel et al (2001) reported 21 cases of black water fever in European 
expatriates who lived in sub-Saharan Africa. The presumed triggers of 
black water fever were halofantrine, quinine, mefloquine and halofantrine 
or quinine (227). 
Clinical features characterized by severe intravascular haemolysis and 
anaemia producing dark urine in patients with severe malaria. Abdominal 
pain, jaundice, hepatosplenomegaly, vomiting, and renal failure have also 
been reported (226). 
The pathogenesis of BWF remains unclear (222, 227). Its management 
changed with the introduction of artemisinin derivates but is still debated. 
Price et al (1999) state that parenteral quinine can be stopped when 
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artemisinin derivatives are available because they seem to be safe and 
well tolerated (228). 
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Rational of the study 
Malaria continues to claim one to three million lives a year mainly those 
of children in sub Saharan Africa. A study in Gambia reported 80% 
deaths to occur during the first day of admission and childhood mortality 
remains unacceptably high (9). In the Sudan, it is responsible for 44.000 
deaths annually (5). Despite the huge literature, the pathophysiological 
mechanisms of severe malaria are still not well known and better 
understanding of these mechanisms and their application may open a 
window for discovery of new therapeutic agents and prevention methods. 
Identifying bad prognostic factors has great advantages in aiding 
clinicians in identification of sickest children who need special care as 
well as targeting resources to children at higher risk.  
 
This project investigates the endocrine and paracrine aspects of the 
pathophysiology of severe malaria in children up to 12 years. This study 
monitors the clinical and laboratory parameters during the early stages of 
severe malaria so as to identify and correct life threatening changes. The 
study also aims to identify indicators of high risk patients.  
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OBJECTIVES 
 
General objectives: To monitor clinical manifestations and selected 
laboratory tests in children with severe malaria so as to identify indicators 
of serious outcomes of the disease. 
 
Specific objectives:  
1. In addition to a comprehensive history, physical examination and 
clinical follow up, the study has focused on the following battery of tests: 
a- Blood glucose homeostasis including insulin and C-peptide assay. 
b- Cytokines (TNF-α, IFN-γ and IL-10) 
c- Haemoglobin and total white blood cells estimation 
d- Hepatic functions  
e- Renal functions  
f- Serum electrolytes  
2- Based on the above, the study aims at recommendation which may 
lead to a cost effective protocol of appropriate laboratory investigations 
and clinical monitoring  
3- Indicators to identify high risk patients would be an essential part of a 
protocol for management of severe malaria in children. 
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CHAPTER TWO 
PATIENTS AND METHODS 
Location and time of the study 
The study was conducted at Wadmedani Paediatric Hospital. The 
collection of samples started in September 2007 and extended up to 
September 2008. 
Patients and controls  
The study included a cohort of fifty six children with severe malaria who 
reported to the hospital within the above period and were included 
according to WHO criteria of SM. Thirty one children with 
uncomplicated malaria were included in the study for comparison. The 
age of both groups ranged from 2 year up to 12 years. Exclusion criteria 
identified patients who had antimalarial treatment before admission, those 
known to have renal disease, hepatic disease, diabetes mellitus or those 
suffering from metabolic disorders as well as malnourished children 
(based on weight for age charts). The study was approved by the 
Institutional Ethical Committee of University of Khartoum and verbal 
consent was obtained from parents of the children. 
History and physical examination 
Both groups of patients underwent a history and comprehensive physical 
examination by the researcher as well as by hospital staff. A data 
collection form was completed for each patient including history, 
physical examination and laboratory findings.  
Malaria diagnosis and blood tests: 
Blood samples 
A sample consisting of 5 ml was taken from each patient on admission 
and before treatment and divided into 3 tubes, one containing EDTA used 
for Hb, TWBCs count and parasitemia estimation. Second tube 
containing fluoride was used for RBG and the third one was a plain tube 
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for the rest of investigations. For each patient thick and thin blood film, 
Hb estimation, TWBCs count, RBG estimation, insulin and C-peptide 
measurement,  urea, creatinine, electrolytes sodium & potassium, total 
bilirubin and differential,  liver enzymes; AST, ALT and ALP and 
Cytokines; TNF-α, IFN-γ and IL-10 were done. 
Malaria diagnosis & parasitemia estimation 
The microscopic identification of the malaria parasite is the method of 
confirmation of infection with plasmodium falciparum used in the study 
to satisfy WHO criteria. Only positive cases were included. The thick 
blood film was used for parasite detection while thin film was used for 
identification of species and parasitemia estimation. 
The thin blood film was fixed using absolute methyl alcohol, and then 
stock solution of Giemsa stain was diluted with distilled water. The 
distilled water was kept at pH 7.1-7.2 using phosphate buffer. Staining of 
films was done. Parasitemia estimated in thin films expressed as a 
percentage of infected RBCs from total RBCs (229).  
Haemoglobin (Hb) estimation 
Haemoglobin was measured by a colorimetric method. Hb was oxidized 
by potassium ferricyanide to methaemoglobin which is in turn converted 
to cyanomethaemoglobin by potassium cyanide. The intensity of color 
produced was proportional to Hb concentration in the sample (230). 
Procedure of test started by preparation of working reagent by mixing 1 
vial of drabkin solution with 245ml of distilled water. Then a set of three 
tubes were prepared. In the blank tube, 5ml of the working reagent was 
added. Into the standard tubes 5ml of the working reagent and 20µl of Hb 
standard were added. Into the sample tubes, 5ml of working reagent and 
20µl of sample were added. Mixing and incubation for three minutes at 
room temperature was done. Absorbance of the sample and standard was 
measured at 540nm against the blank. 
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Total white blood cells (TWBCs) count 
TWBCs were counted in haemocytometer after mixing of 0.02ml of 
blood with 0.38ml of glacial acetic acid (231).   
Random blood glucose measurement 
RBG was measured by enzymatic colorimetric method. The glucose was 
oxidized to gluconate in the presence of glucose oxidase with formation 
of hydrogen peroxide. Hydrogen peroxide oxidizes the mixture of phenol 
and 4-aminoantipyrine to red quinoneimine dye proportional to 
concentration of the glucose present in the sample (232). 
The test began with preparation of a set of three tubes then 1ml of reagent 
was added to each of the three tubes. The first tube is considered the 
blank, to second tube 10µl of sample was added and labeled as sample 
tube and to the third tube 10µl of standard was added and labeled as 
standard tube. The three tubes were incubated for 10 minutes at room 
temperature, and then absorbance of standard and sample were road at 
500 nm against the reagent blank. 
Hormone assays  
Insulin and C-peptide measurement 
Insulin and C-peptide concentrations were measured in the serum using 
radioimmunoassay. 
Principle of radioimmunoassay 
The radioimmunoassay in this test depends upon the competition iodine-
125 labeled analyte (insulin and C-peptide) and the analyte in the patient 
sample or in the standard for the limited number of binding site on the 
analyte specific antibody. After incubation for a fixed time, separation of 
the bound from free is achieved by polyethylen glycol-accelerated double 
antibody procedure. The tube then counted in a gamma counter, the 
counts being inversely related to the amount of analyte present in the 
patient sample. By measuring the proportion of iodine-125 labeled 
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analyte bound in the presence of varying known amount of analyte 
standards, the concentration of the analyte in unknown samples can be 
interpolated (233). 
Procedure of insulin assay  
Procedure of insulin assay started by labeling and arrangement of test 
tubes according to the scheme protocol of the kit producers then 100µl of 
the insulin standards solution and the unknown samples were pipetted 
into the appropriate test tubes. This step was followed by addition of 
100µl of insulin antibody solution to all tubes except total and non 
specific binding tubes. Then 100µl of iodine-125 labeled insulin solution 
were added to all tubes except the blanks and all test tubes were 
incubated at 37ºC for 2 hours. 500µl of the separating solution were 
added to all tubes except total count tube and the tubes were mixed and 
incubated at 37ºC for 15 minutes. All test tubes were centrifuged (except 
total count tube) at 1500 rpm for 15 minutes and the supernatant of all 
tubes were decanted. Finally all the tubes were counted in a gamma 
counter. 
Procedure of C-peptide assay 
Test tubes were labeled and arranged according the scheme protocol then 
100µl of the C-peptide standards solution and the unknown samples were 
pipetted into the appropriate tubes. 100µl of C-peptide antibody solution 
were added to all tubes except total and non specific binding tubes 
followed by addition of  100µl of iodine-125 labeled C-peptide solution 
and incubation of all test tubes at 4ºC for 24 hours. Then 500µl of the 
separating solution were added to all tubes except total count tube, then 
the tubes were mixed and incubated at 37ºC for one hour. The supernatant 
of all tubes were decanted and all the tubes were counted in a gamma 
counter. 
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Urea measurement 
Urea is measured by a UV enzymatic method using spectrophotometer. 
Urea was hydrolyzed by urease to ammonia and carbon dioxide. The 
ammonia is then converted to glutamate by glutamate dehydrogenase in 
the presence of oxoglutarate and NADH. The reaction is then monitored 
kinetically at 340nm by the rate of decrease in absorbance resulting from 
the oxidation of NADH to NAD+ proportional to concentration of urea 
present in the sample (234). 
Procedure of the test started by preparation of the working reagent by 
mixing 4ml of reagent one which contain urease enzyme with 1ml of 
reagent two which is the buffered chromogen. The working reagent, 
standard and samples were incubated at 37°C. One ml of working reagent 
was added to set of two tubes, one containing 10µl of sample and the 
other containing 10µl of standard.  Inversion of both tubes several times 
was done. The spectrophotometer was set to zero absorbance by distilled 
water. The absorbance of both tubes was measured at 340nm at different 
fixed time and then the concentration of urea was estimated.   
Creatinine measurement 
Creatinine was measured by a kinetic method. Creatinine under alkaline 
condition reacts with picrate ions forming a reddish complex. The 
formation rate of complex measured through the increase in absorbance 
in a prefixed interval of time is proportional to the concentration of 
creatinine in the sample (235). 
Procedure of the test started by preparation of the working reagent by 
mixing one volume of reagent one (picric acid) with one volume of 
reagent two (alkaline buffer). The working reagent, standard and samples 
were incubated at 37°C. One ml of working reagent was added to set of 
two tubes, one containing 100µl of sample and the other containing 100µl 
of standard.  Mixing of each tube was done. The spectrophotometer was 
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set to zero absorbance by distilled water. The absorbance of both tubes 
was measured at 510nm at different fixed time and then the concentration 
of creatinine was estimated. 
Sodium and potassium measurement 
Sodium and potassium were measured in serum samples using a flame 
photometer (236).  
Procedure of the test involved addition of 0.1 ml of sample to 9.9 ml of 
distilled water in a test tube before measurement in the flame photometer. 
Bilirubin measurement 
Bilirubin was measured using a colorimetric method. Bilirubin was 
converted to color azobilirubin by sulfanilic acid and measured 
photometrically. Bilirubin glucuronide reacts directly in aqueous solution 
while indirect bilirubin requires solubilization with dimethylsulfoxide to 
react (237). 
Procedure of determination of total bilirubin started with prepation of the 
working reagent by mixing 4ml of reagent totat (RT) and 1ml of sodium 
nitrate. Then a set of four tubes was prepared. Into sample blank tube 
100µl of sample and 1ml of RT were added. In the sample tubes, 100µl of 
sample, 1 ml of working reagent were added. In the calibrator blank 
100µl of distilled water, 1ml of working reagent were added. Into the 
calibrator tube 100µl of calibrator and 1ml of working reagent were 
added.  Then the tubes were mixed thoroughly and allowed to stay for 
two minutes at room temperature. The absorbance of sample blank was 
measured at 540nm against distilled water and that of sample against 
calibrator blank.  
For determination of direct bilirubin, working reagent was prepared by 
mixing 4ml of reagent direct (RD) and 1ml of sodium nitrate. Then a set 
of four tubes was prepared. Into sample blank tube 100µl of sample and 
1ml of RD were added. In the sample tubes, 100µl of sample, 1 ml of 
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working reagent were added. In the calibrator blank 100µl of distilled 
water, 1ml of working reagent were added. Into the calibrator tube 100µl 
of calibrator and 1ml of working reagent were added. Then the tubes 
were mixed thoroughly and allowed to stay for two minutes at room 
temperature. The absorbance of sample blank was measured at 540nm 
against distilled water and that of sample against calibrator blank.    
Alanine aminotransferase (ALT) measurement 
ALT was measured by UV enzymatic method. ALT catalyzes the transfer 
of amino group from alanine to oxoglutarate with the formation of 
glutamate and pyruvate. The latter was reduced to lactate by adding 
lactate dehydrogenase in the presence of NADH. The reaction was 
monitored kinetically at 340nm by the rate of decrease in absorbance 
resulting from the oxidation of NADH to NAD+ which is proportional to 
the activity of ALT present in the sample (238). 
Procedure of the test started by preparation of the working reagent by 
mixing 4ml of reagent one (ALT substrate) with 1ml of reagent two (ALT 
coenzyme). Then working reagent, standard and samples were incubated 
at 37°C. One ml of working reagent was added to set of two tubes, one 
containing 50µl of sample and the other containing 50µl of standard. 
Mixing by inversion of both tubes several times was done. The 
spectrophotometer was set to zero absorbance by distilled water. The 
absorbance of both tubes was measured at 340nm at different fixed time 
and then the concentration of ALT was estimated.  
Aspartate aminotransferase (AST) measurement 
AST was measured by a UV enzymatic method. AST catalyzes the 
transfer of amino group from aspartate to oxoglutarate with the formation 
of glutamate and oxaloacetate. The latter is reduced to malate by malate 
dehydrogenase in the presence of NADH. The reaction was monitored 
kinetically at 340nm by the rate of decrease in absorbance resulting from 
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the oxidation of NADH to NAD+ which is proportional to the activity of 
AST present in the sample (239). 
Procedure of the test began with preparation of the working reagent by 
mixing 4ml of reagent one (AST substrate) with 1ml of reagent two (AST 
coenzyme). Working reagent, standard and samples were incubated at 
37°C. One ml of working reagent was added to set of two tubes, one 
containing 50µl of sample and the other containing 50µl of standard.  
Mixing was achieved by inversion of both tubes several times. The 
spectrophotometer was set to zero absorbance by distilled water. The 
absorbance of both tubes was measured at 340nm at different fixed time 
and then the concentration of ALT was estimated.  
Alkaline phosphatase (ALP) measurement 
ALP was measured by colorimetric method. ALP catalyzes the hydrolysis 
of 4-nitrophenyphosphate to 4- nitrophenol and inorganic phosphate. The 
reaction was monitored kinetically at 405nm by the rate of formation of 
4-nitrophenol which is proportional to the activity of ALP present in the 
sample (240).  
Procedure of the test started by preparation of the working reagent by 
mixing 4ml of reagent one (ALP buffer) with 1ml of reagent two (ALP 
substrate). Then working reagent, standard and samples were incubated at 
37°C. One ml of working reagent was added to set of two tubes, one 
containing 20µl of sample and the other containing 20µl of standard.  
Inversion of both tubes several times was done. The spectrophotometer 
was set to zero absorbance by distilled water. The absorbance of both 
tubes was measured at 405nm at different fixed time and then the 
concentration of ALT was estimated.  
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Cytokines measurement 
Measurement of serum cytokines was done using ELISA technique.  
ELISA principle 
The assay is based on a blend of antibodies directed against the cytokine. 
These antibodies are fixed to the surface of the wells. Standards or 
samples, containing the cytokine, react with the antibodies coated in the 
well and with antibodies labeled with enzyme. After the incubation 
period at predetermined time allowing the formation of sandwich, the 
plate is washed to remove unbound enzyme labeled antibodies. Then, 
substrate solution is added and incubated. The reaction is stopped by stop 
solution. The plate is then read at appropriate wavelength. The amount of 
substrate turnover is determined colorimetrically by measuring the 
absorbance which is proportional concentration. Standard curve is plotted 
and cytokine concentration is determined by interpolation from the 
standard curve (241). The procedure followed were those recommended 
by kit manufacturer.  
Procedure of IFN-γ assay 
The assay started by addition of 50µl of each standard, control and 
samples to appropriate well then 50µl of anti- IFN-γ conjugate were 
added into all the wells. Incubation for 2 hours at room temperature on a 
horizontal shaker set at 700 rpm± 100 rpm was allowed and followed by  
washing of the plate using an automatic washer. Then 200µl of freshly 
prepared chromogenic solution were added into all the wells followed by 
incubation for 15 minutes at room temperature on a horizontal shaker set 
at 700 rpm ± 100 rpm. The reaction was stoped by addition of 50µl of 
stop solution for each well. Absorbance was read at 450nm and 490 and 
the standard curve was plotted using optical density against standard 
concentrations.  
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Procedure of TNF-α assay 
At the beginning of assay, 50µl of standard, samples and sample diluent 
were added into appropriate wells then the test tubes were incubated for 
1hour at room temperature. Washing was done 5 times followed by 
addition of 50µl of biotin antibody into each well and the tubes again 
incubated for 30 minutes at room temperature. Another washing was 
done 5 times followed by addition of 50µl of HRP-streptavidin solution 
into each well. Incubation for 30 minutes at room temperature was 
allowed and followed by washing 5 times. Then 50µl of TMB substrate 
solution into were added to each well followed by incubation for 20 
minutes at room temperature and addition of 25µl of stop solution. 
Absorbance was read at 450nm against 630nm  
 Procedure of IL-10 assay 
Procedure of IL-10 assay was started by addition of 50µl of standard, 
samples and sample diluent into appropriate wells then 50µl of biotin 
antibody were added into each well. Incubation for 1 hour 30 minutes at 
room temperature was allowed followed by washing 5 times. Then 1ooµl 
of HRP-streptavidin solution was added into each well and the wells were 
incubated for 30 minutes at room temperature which was followed by 
washing 5 times. Then 50µl of TMB substrate solution into each well and 
incubation for 20 minutes at room temperature was allowed. This step 
was followed by addition of 25µl of stop solution into each well. 
Absorbance was read at 450nm against 630 nm. 
Statistical methods: 
Statistical analysis was carried out with stastical package of social 
sciences (SPSS) for windows version 11.5.  SPSS version 15 was used to 
display correlation graphs. Normality of data distribution was checked 
using Kolmogrov-Smirnov test. Data were presented as means and 
standard deviations and analyzed by Student's T test. Correlations were 
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compared using the χ2 tests if the variables were qualitative, Pearson's 
correlation coefficient was used for quantitive variables and Spearman' 
rank correlation coefficient tests was used to correlate quantitive variable 
with qualitive variable. Assessments of prognostic factors were 
conducted with regression model. P values < 0.05 were considered as 
significant.  
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CHAPTER THREE 
RESULTS 
Sample characteristics 
The total number of patients with malaria included in the study was 87 
patients. WHO guidelines for severe malaria were used to divide the 
patients into two categories; uncomplicated malaria (UM) and severe 
malaria (SM) cases.  Sample characteristics are shown in the table below 
Table-1 Sample characteristics 
P value SM UM Character 
 56 31 Number 
0.001 56.75(24-
144) 
82.71( 26-144) Age(months) 
mean &range 
0.458  
26(46.4%) 
30(53.6)
 
17(54.8%)       
14(45.2%)
Gender 
Male 
female 
Shaded box indicate significance. 
Figure-1 Age distribution of UM and SM 
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Severe malaria affects younger children while uncomplicated malaria 
affects older children (figure-1). Significant difference was found 
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between the two means (P value=0.001). In comparing the means of 
different severe malaria categories, children with severe anaemia and 
repeated convulsions were younger than those with cerebral malaria.  
Haemoglobinuric patients were significantly older than those without 
haemoglobinuria (P value=0.007). There was a significant association 
between the age of the child and presenting category of malaria (P 
value=0.000).  
Clinical presentation 
Fever, nausea and vomiting were the most common symptoms of children 
having uncomplicated malaria. Jaundice and hepatosplenomegaly were 
infrequent in this group. In children with severe malaria fever and 
repeated convulsions were the most frequent presenting features.   
Table-2 The clinical presentation of children with malaria 
SM- 
percentage 
SM-
number
UM-percentage UM-
number 
Clinical feature 
100 56 100 31 Fever 
30.4 1735.511 Cough 
14.3 8 0 0 Shortness of 
breath 
37.5 21 61.3 19 Nausea 
37.5 21 61.3 19 Vomiting 
17.9 10 32.3 10 Diarrhea 
41.1 23 6.5 2 Convulsions 
83.9 4745.214 Tackycardia 
71.4 40 32.3 10 Tackypnoea 
14.3 8 3.2 1 Jaundice 
19.6 11 6.5 2 Hepatomegaly 
21.4 12 0 0 Splenomegaly 
23.2 13 -  Cerebral malaria 
23.2 13 -  Severe anaemia 
1.8 1 -  Hypoglycemia 
3.6 2 -  Haemoglobinuria 
7.1 4 -  Mixed 
presentation 
 
 59
Table-3: Laboratory investigation of UM & SM 
P 
value 
SM 
( mean ±SD)  
 
UM 
(mean± SD)      
Kolmogro
v-Smirnov 
test P 
value 
Investigation 
0.035 89.27±39.06 108±39.14 0.367 RBG(mg/dl) 
0.39825.14±14.72 22.784±6.140.076 Urea(mg/dl) 
0.016 0.40±0.32 0.561±0.22 0.063 Creatinine(mg/dl) 
0.056 133.20±4.65 135.03±3.30 0.200 Na+(mmol/l) 
0.4743.98±1.04 3.84±0.410.067 K+(mmol/l) 
0.118 26.96±20.83 34.61±23.09 0.271 AST(U/L) 
0.401 19.86±12.96 22.48±15.44 0.203 ALT(U/L) 
0.959 398.89±144.3
1 
400.48±120.95 0.697 AIP(U/L) 
0.016 1.130±0.99 0.681±0.28 0.575 Total 
bilirubin(mg/dl) 
0.000 7.54±2.71 9.91±1.67 0.871 Hb(g/dl) 
0.009 8169.64±553
6.26 
5419.35±1661.
61 
0.566 TWBCs(cell/µl) 
Shaded boxes indicate significance. 
Each two means were compared using the Student’s T test. 
Blood glucose 
The mean blood glucose level in uncomplicated malaria was 108.06mg/dl 
while severe malaria group had mean blood glucose of 89.27mg/dl. The 
difference between the two means was significant (P value =0.035). 
Hypoglycemic patients and those with mixed presentation had the lowest 
blood glucose and showed significant differences when compared to 
children with uncomplicated malaria. 
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Table-4 Comparison of RBG between UM&SM categories 
Shaded boxes indicate significance. 
Insulin 
The mean insulin level in UM was 8.35mIU/L while in SM was 
8.87mIUl/L. No significant difference was found (P value=0.754). Three 
cases of hyperinsulinemia were found in the severe malaria group.  No 
significant differences were found between clinical categories of severe 
malaria and UM. 
Table-5 Comparison of insulin between UM & SM categories 
 
C-peptide 
The mean of C-peptide in UM was 1.04ng/ml while in SM 1.88ng/ml. No 
significant difference was found between the two (P value=0.172). 
Children with severe anaemia and mixed presentation had significantly 
higher C-peptide level than those with UM. 
PvalueMean ±SD 
 
NumberSM categories UM (mean±SD) 
0.311 95.54±30.82 13 Cerebral malaria 108.06±39.14 
0.031 79.92±35.91 13 Severe anaemia  
0.467 100.17±39.06 23 Repeated 
convulsions 
 
0.039 22.00 1 Hypoglycemia  
0.627 94.00±43.84 2 Haemoglobinuria 
0.011 51.00±47.51 4 Mixed 
presentation 
 
P 
value 
Mean ±SD 
 
NumberSM categories UM(mean±SD) 
0.286 11.29±14.57 12 Cerebral malaria 8.35±3.01 
0.241 7.25±1.74 12 Severe anaemia  
0.622 9.18±8.59 23 Repeated 
convulsions 
 
0.639 6.91 1 Hypoglycemia  
0.658 7.39±0.81 2 Haemoglobinuria 
0.125 5.94±1.07 4 Mixed 
presentation 
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Table-6 Comparison between C-peptide in UM & SM categories 
Shaded boxes indicate significance. 
Insulin: C-peptide ratio 
The ratio of Insulin: C-peptide ratio in UM was 0.22 while in SM 0.18. 
 No significant difference was found in between two (P value=0.074). 
Children with mixed presentation had significantly lower ratio than UM. 
 
Figure-2 Ratio of insulin to C-peptide in UM & S 
presentation
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P 
value 
Mean ±SD 
 
NumberSM categories UM (mean±SD) 
0.099 1.99±2.94 13 Cerebral malaria 1.04±0.65 
0.045 3.31±6.07 10 Severe anaemia  
0.452 0.92±0.46 22 Repeated 
convulsions 
 
0.448 0.53 1 Hypoglycemia  
0.725 0.87±0.25 2 Haemoglobinuria 
0.000 4.15±4.17 4 Mixed 
presentation 
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Table-7 Comparison between insulin: C-peptide ratio in UM & SM 
categories 
Shaded box indicate significance. 
Correlation between insulin and blood glucose 
Significant positive correlation was found between insulin and blood 
glucose (P value= 0.006) using Pearson's correlation coefficient. 
 
 Figure-3 Correlation between blood glucose and insulin 
 
PvalueMean ±SD 
 
NumberSM categories UM (mean±SD) 
0.066 0.15±0.07 12 Cerebral malaria 0.22±0.11 
0.192 0.16±0.11 9Severe anaemia 
0.628 0.21±0.11 22 Repeated 
convulsions 
 
0.629 0.28 1 Hypoglycemia  
0.634 0.18±0.03 2Haemoglobinuria 
0.022 0.08±0.09 4 Mixed 
presentation 
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Correlation between insulin and C-peptide 
Significant positive correlation was found between insulin and C-peptide 
(P value=0.000) using Pearson's correlation coefficient. 
 
Figure-4 Correlation between insulin and C-peptide 
 
Table-8 Expected value of insulin to C-peptide ratio in UM & SM 
Parameter UM SM 
Recorded insulin 
pmol/l 
50.14 53.24 
C-peptide pmol/l 290.23 524.66 
Expected value of 
insulin 
58.04 104.93 
 
Haemoglobin 
The mean Hb level in uncomplicated malaria was 9.91g/dl while severe 
malaria group had mean Hb of 7.54g/dl. A significant difference was 
found between the two means (P value=0.000). Children with severe 
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anaemia and mixed presentation as well as those with cerebral malaria 
had the lowest Hb levels and significant differences were found between 
their means and uncomplicated malaria. 
 
Table-9 Comparison of Hb between UM & SM categories 
P value Mean ±SDNumberSM categoriesUM ( g/dl) 
0.008 8.39±1.55 13 Cerebral 
malaria 
9.91±1.67 
0.000 4.05±0.77 13 Severe anaemia  
0.060 8.93±2.03 23 Repeated 
convulsions 
 
0.204 7.70 1 Hypoglycemia  
0.435 10.90±2.682 Haemglobinuria 
0.001 6.40±3.27 4 Mixed  
presentation 
 
Shaded boxes indicate significance. 
Total white blood cells count 
The mean total white blood cells count of uncomplicated malaria was 
5419.35 cells/ µl while in severe malaria 8169.64 cells/µl. A significant 
difference was found between the two means (P value=0.009). Children 
with mixed presentation, cerebral malaria and repeated convulsions had 
the highest TWBCs count 
 
Table-10 Comparison of TWBCs between UM & SM categories 
P 
value 
Mean ±SD NumberSM categories UM 
0.0018307.69±3635.03 13 Cerebral malaria 5419.35+1661.61 
0.34 6092.31±2986.77 13 Severe anaemia  
0.0067465.22±3488.76 23 Repeated 
convulsions 
 
0.2277500 1 Hypoglycemia  
.57206100±141.42 2 Haemoglobinuria 
0.00019725± 13433.63 4 Mixed 
presentation 
 
Shaded boxes indicate significance. 
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Bilirubin 
The mean bilirubin level in uncomplicated malaria was 0.68 mg/dl and in 
severe malaria 1.13mg/dl. A significant difference was found between the 
two means (P value=0.016). Children with mixed presentation, cerebral 
malaria and repeated convulsions had the highest total bilirubin level 
which was mainly of the unconjugated form. A significant correlation 
was found between bilirubin and urea (P value=0.000) and between 
bilirubin and creatinine (P value=0.001) using Pearson's correlation 
coefficient. 
Table- 11 Comparison of bilirubin between UM & SM 
P 
value 
Mean ±SD NumberSM categories UM 
0.002 1.16±0.68 13 Cerebral malaria 0.68+0.28 
0.125 0.89±0.61 13 Severe anaemia  
0.013 1.06±0.76 23 Repeated 
convulsions 
 
0.112 0.20 1 Hypoglycemia  
0.700 0.60±0.00 2 Haemoglobinuria 
0.000 2.67±2.53 4 Mixed 
presentation 
 
Shaded boxes indicate significance. 
Liver enzymes 
No significant differences were found between liver enzymes of 
uncomplicated and severe malaria as well as in comparing uncomplicated 
malaria with different severe malaria categories, however children with 
severe malaria had a significantly higher frequency of high levels of these 
enzymes when compared to uncomplicated malaria using χ2 test for 
goodness of fit. 
Table -12 Mean of AST. ALT & ALP in UM & SM 
P value SM UM Enzyme 
0.118 26.96±20.83 34.61±23.09 AST 
0.401 19.86±12.96 22.48±15.48 ALT 
0.959 398.89±144.31400.48±120.95ALP 
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Table-13 Comparison of AST between UM & SM 
P 
value 
Mean ±SD Number SM categories UM 
0.602 38.92±28.61 13 Cerebral malaria 34.61±23.09 
0.061 21.08±16.03 13 Severe anaemia  
0.183 26.83±17.68 23 Repeated 
convulsions 
 
0.232 6.00 1 Hypoglycemia  
0.148 10.00±5.65 2 Haemoglobinuria 
0.288 21.75±14.38 4 Mixed 
presentation 
 
 
 
Figure-5 AST in UM & SM 
presentation
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1=uncomplicated malaria 
2=severe malaria 
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Table-14 Comparison of ALT between UM & SM categories 
P 
value 
Mean ±SD Number SM categories UM 
0.602 19.85±14.14 13 Cerebral malaria 22.48±23.09 
0.061 19.62±11.87 13 Severe anaemia  
0.183 21.17±13.58 23 Repeated 
convulsions 
 
0.232 2.00 1 Hypoglycemia  
0.148 11.50±9.19 2 Haemoglobinuria 
0.288 21.75±12.86 4 Mixed 
presentation 
 
 
Figure-6 ALT in UM & SM 
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Table-15 Comparison of ALP between UM & SM categories 
P 
value 
Mean ±SD Number SM categories UM 
0.480 368.23±170.23 13 Cerebral malaria 400.48±120.95 
0.989 401.08±151.00 13 Severe anaemia  
0.750 389.74±123.48 23 Repeated 
convulsions 
 
0.021 700.00 1 Hpoglycemia  
0.766 373.50±178.89 2 Haemoglobinuria 
0.206 481.50±87.93 4 Mixed 
presentation 
 
 
 
Figure-7 ALP in UM&SM 
presentation
3210
AL
P
800
700
600
500
400
300
200
100
0
 
1=uncomplicated malaria 
2=severe malaria 
Urea 
The mean urea level in uncomplicated malaria was 22.78mg/dl while in 
severe malaria 25.14mg/dl. No significant difference was found between 
the two (P value=0.398). In comparing uncomplicated malaria with 
 69
different severe malaria categories, significant difference was found with 
mixed presentation (P value=0.000). 
 
Table-16 Comparison of urea between UM & SM categories 
P 
value 
Mean ±SD Number SM categories UM 
0.052 27.4±8.71 13 Cerebral malaria22.78±6.14 
0.536 21.35±8.59 13 Severe anaemia  
0.573 21.74±7.30 23 Repeated 
convulsions
 
0.286 16.00 1 hpoglycemia  
0.401 19.00±4.24 2 haemoglobinuria 
0.000 55.00±39.54 4 Mixed 
presentation
 
Shaded box indicate significance. 
Creatinine 
The mean creatinine level in uncomplicated malaria was 0.56mg/dl while 
in severe malaria 0.40mg/dl. A significant difference was found between 
the two (P value=0.016). Children with haemoglobinuria, hypoglycemia, 
repeated convulsions and severe anaemia showed significant differences 
in comparison with uncomplicated malaria. 
 
Table-17 Comparison of creatinine between UM& SM categories 
P 
value
Mean ±SD Number SM categories UM 
0.054 0.41±0.21 13 Cerebral malaria 0.56±0.22 
0.011 0.36±0.22 13 Severe anaemia  
0.001 0.36±0.15 23 Repeated 
convulsions 
 
0.052 0.10 1 Hypoglycemia  
0.032 0.20±.00 2 Haemoglobinuria 
0.082 0.90±.94 4 Mixed 
presentation
 
Shaded boxes indicate significance. 
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Sodium 
The mean sodium level in uncomplicated malaria was 135mmol/l while 
in severe malaria 133mmol/l no significant difference was found between 
the two. Children with severe anaemia and repeated convulsions had 
significantly lower sodium level in comparison with uncomplicated 
malaria. However, a total of fifty children were found to be 
hyponatremic, most of them had severe malaria. Incidence of 
hyponatremia was more frequent in severe malaria than uncomplicated 
malaria (P value=0.005) using χ2 tests for goodness of fit. 
 
Figure-8 Frequency of hyponatremia in SM 
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Table-18 Comparison of sodium between UM & SM categories 
P 
value 
Mean ±SD Number SM categories UM 
0.206 133.31±5.52 13 Cerebral malaria 135.03±3.30 
0.027 132.38±3.94 13 Severe anaemia  
0.028 132.65±4.42 23 Repeated 
convulsions 
 
0.149 140 1 Hypoglycemia  
0.696 134.00±8.48 2 Haemoglobinuria 
0.405 136.50 ±3.00 4 Mixed 
presentation 
 
Shaded boxes indicate significance 
Potassium 
Although the mean potassium level in uncomplicated malaria showed no 
significant difference compared with severe malaria, hypokalaemia was 
found to be significantly more frequent in severe malaria than 
uncomplicated malaria (P value=0.039) using χ2 test for goodness of fit. 
Those children who had hyperkalaemia presented mostly with 
neurological manifestation in the form of cerebral malaria or repeated 
convulsions and one of them died.  
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Figure-9 Incidence of hypokalaemia and hyperkalaemia in UM & SM 
presentation
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Table-19 Comparison of potassium between UM & SM categories 
P 
value 
Mean ±SD Number SM categories UM 
0.5144.02±1.38 13Cerebral malaria3.84±0.41 
0.477 3.97±.80 13 Severe anaemia  
0.232 4.09±1.02 23 Repeated 
convulsions 
 
0.4054.201Hypoglycemia 
0.455 3.99±.80 2 Haemoglobinuria 
0.578 3.70±.94 4 Mixed 
presentation 
 
 
Association between the course of malaria and the clinical categories 
There is significant association between the clinical categories of malaria 
and course of the disease in the form of length of hospital stay and 
survival (P value=0.000) using Spearman' rank correlation coefficient 
test. 
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Table-20 Clinical categories of malaria and outcome 
Death Increase 
morbidity(>2days) 
Short hospital 
stay(≤2 days) 
NumberClinical 
categories of 
malaria 
0 0 31(100%) 31 Uncomplicated 
malaria 
1(1.8%)4 (7.2%)51(91%)56 Severe malaria 
1(7.69%)  1 (7.69%) 11(84.61%) 13 Cerebral 
malaria 
0 3 (75%) 1 (25%) 4 Mixed 
presenentation 
 
Mixed presentation 
Children with mixed presentation were found to have low RBG and 
haemoglobin in comparison with children who had uncomplicated 
malaria. Also, they had high total white blood cells count, bilirubin and 
urea.  
Table-21 The RBG, Hb, bilirubin, TWBCs and urea of uncomplicated 
malaria and mixed presentation 
P value Mixed 
presentatiom 
( mean ±SD) 
Uncomplicated 
malaria                 ( 
mean ±SD) 
Investigation 
0.011 51±47.51 108±39.14 RBG 
0.001 6.4±3.27 9.910±1.67 Hb 
0.000 2.675±2.53 0.68±0.28 Bilirubin 
0.000 19725±13433.635419.35±1661.61 TWBCs 
0.000 55.000±39.54 22.78±6.14 Urea 
0.578 3.700±.94 3.84±0.41 K 
Shaded boxes indicate significance. 
Cerebral malaria 
Children with cerebral malaria were found to have high total white blood 
cells count and bilirubin and low haemoglobin in comparison with 
children with uncomplicated malaria. 
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Table-22 The Hb, bilirubin and TWBCs of uncomplicated malaria and 
cerebral malaria 
P value Cerebral malaria Uncomplicated 
malaria 
Investigation 
0. 008 8.39±1.55 9.91±1.67 Hb 
0.002 1.16±0.68 0.68±.28 Bilirubin 
0.001 8307.69±3635.035419.35±1661.61TWBCs 
Shaded boxes indicate significance. 
Parasitemia 
About 30.4% of children with severe malaria were found to have 
hyperparasitemia while 19.4% of those with uncomplicated malaria had 
hyperparasitemia. The incidence of hyperparasitemia was found to more 
in severe malaria than in uncomplicated malaria (P value=0.022) using 
χ2 test for goodness of fit. Negative correlation were detected between 
parasitemia and Hb (P value=0.004) using Pearson's correlation 
coefficient test. Also significant negative correlation were found between 
parasitemia and RBG (P value=0.017) using Pearson's correlation 
coefficient test. No significant correlation were found between the degree 
of parasitemia and clinical categories of malaria (P value=0.214) using 
Spearman' rank correlation coefficient as well as with potassium (P 
value=0.298), sodium (P value=0.244), TNF-α (P value=0.388), IL-10 (P 
value=0.072) and IFN-γ (P value=0.146). The later five correlations were 
analyzed by Pearson's correlation coefficient test. 
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Figure-10 Degree of parasitemia in UM & SM 
presentation
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Figure-11 Correlation between parasitemia and haemoglobin 
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Figure-12 Correlation between parasitemia and blood glucose 
 
 
 
Period of illness 
The mean period of illness (days of illness before admission) in UM was 
2.13 days while in SM was 2.41 days. No significant difference was 
found (P value=0. 476). Children with severe anaemia had a significantly 
prolonged period of illness in comparison to UM (P value=0.001). 
Significant negative correlation was found between period of illness and 
Hb (P value=0.001), RBG (P value=0. 041) and IFN-γ (P value=0.001) 
using Pearson's correlation coefficient test. 
. 
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Table-23 Comparison of period of illness between UM & SM 
P 
value 
Mean ±SD Number SM categories UM 
0.841 2.23±1.30 13 Cerebral malaria 2.13±1.60 
0.001 4.46±2.57 13 Severe anaemia  
0.150 1.61±0.65 23 Repeated 
convulsions 
 
0.938 2 1 Hypoglycemia  
0.912 2±0.000 2 Haemoglobinuria 
0.290 1.25±0.50 4 Mixed 
presentation 
 
Shaded box indicate significance 
TNF-α 
The mean of TNF-α of uncomplicated malaria was 238.91pg/ml while in 
severe malaria was 178.52pg/ml no significant difference was found 
between the two (P value=0.675). No significant differences were found 
between severe malaria categories and uncomplicated malaria however 
children with cerebral malaria had a significantly higher TNF-α than 
those without cerebral malaria (P value=0.035). Significant difference 
was found between cerebral malaria and severe anaemia (P value=0.029) 
Positive correlation between TNF-α and RBG was noted but it wasnot 
reach significance in both UM and SM (P value=0.798 and 0.172 
respectively). Multiple regression models revealed a significant relation 
between TNF-α and ALT and ALP. TNF-α positively correlated with 
ALT (P value=0.014) when they analyzed by Pearson's correlation 
coefficient test.  
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Figure-13 TNF-α in children with cerebral malaria and those without 
cerebral malaria 
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Figure-14 TNF-α in different malaria cateories 
 
Table-24 Comparison of TNF-α in UM & SM categories. 
P 
value 
Mean ±SD NumberSM categories UM 
0.931 258.66±574.81 13 Cerebral malaria 238.91±725.20 
0.33239.70±61.43 13Severe anaemia 
0.970 246.92±813.94 23 Repeated 
convulsions 
 
0.748 0.00 1 Hypoglycemia  
0.76682.70±49.35 2Haemoglobinuria 
0.646 68.40±61.82 4 Mixed 
presentation 
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Table-25 Correlation of TNF-α with clinical and laboratory parameters  
Parameter P value
Age 0.259
Sex 0.385
Hepatomegaly 0.082
Splenomegaly 0.182
Period of illness 0.564
Temperature 0.912
Parasitemia 0.388
Hb 0.562
RBG 0.421
Insulin 0.650
C-peptide 0.466
TWBCs 0.225
Total bilirubin 0.578
Direct bilirubin 0.713
Indirect bilirubin 0.575
AST 0.480
ALT 0.014
ALP 0.252
Urea 0.949
Creatinine 0.704
Sodium 0.751
Potassium 0.632
IL-10 0.879
IFN-γ 0.161
Outcome 0.152
Shaded box indicate significance 
IFN-γ 
The mean of IFN-γ in uncomplicated malaria was 4.81 IU/ml while in 
severe malaria 4.20IU/ml no significant difference was found  
(P value=0.083). No significant differences were detected between 
uncomplicated malaria and severe malaria categories. However, IFN-γ 
was found to correlate positively with Hb (P value=0.009), RBG (P 
value=0.001), temperature (P value=0.024), period of illness (P 
value=0.001) (correlations were analyzed by Pearson's correlation 
coefficient test), splenomegaly (P value=0.025) and with hepatomegaly 
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(P value=0.01) using Spearman' rank correlation coefficient test. Children 
with severe anaemia had a significantly low IFN-γ than those without 
severe anaemia (P value=0.000).  Significant difference was found in 
IFN-γ between cerebral malaria and severe anaemia (P value=0.002) and 
between severe anaemia and repeated convulsions (P value=0.010) as 
well as between severe anaemia and mixed presentations (P 
value=0.032). About 14.9% of children were found to have IFN-γ values 
above 10 IU/ml of whom 46% present with repeated convulsions, 46% 
with UM and 8% with CM. Most of these patients were found to have 
low parasitemia. 
 
Figure-15 IFN-γ in children with severe anaemia and those without 
severe anaemia   
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Figure-16 Correlation of IFN-γ with haemoglobin 
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Figure-17 Correlation of IFN-γ with random blood glucose 
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Figure-18 IFN-γ in different malaria categories 
  
 
Table-26 Comparison of IFN-γ level in UM & SM categories 
P 
value
Mean ±SD NumberSM categories UM 
0.690 3.55±9.52 13 Cerebral malaria 4.81±9.43 
0. 087 0.20±0.15 13 Severe anaemia  
0.354 7.58±12.40 23 Repeated 
convulsions
 
0.656 0.50 1 Hypoglycemia  
0.995 4.85±6.43 2 Haemoglobinuria 
0..374 0.50±0.38 4 Mixed 
presentation 
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Table-27 Correlation of IFN-γ with clinical and laboratory parameters  
Parameter P value
Age 0.967
Sex 0.976
Hepatomegaly 0.000
Splenomegaly 0.025
Period of illness 0.001
Temperature 0.024
Parasitemia 0.146
Hb 0.009
RBG 0.000
Insulin 0.527
C-peptide 0.752
TWBCs 0.103
Total bilirubin 0.302
Direct bilirubin 0.052
Indirect bilirubin 0.609
AST 0.408
ALT 0.363
ALP 0.277
Urea 0.124
Creatinine 0.475
Sodium 0.605
Potassium 0.495
IL-10 0.104
TNF-α 0.443
Outcome 0.754
Shaded boxes indicate significance 
IL-10 
The mean of IL-10 in uncomplicated malaria was 237.71pg/ml while in 
severe malaria 201.67pg/ml no significant difference was found  
(P value=0.083). A Significant difference was found between children 
with severe anaemia and those with uncomplicated malaria. IL-10 was 
found to correlate with Hb level (P value=0.003) and negatively correlate 
with potassium (P value=0.044) when analyzed by Pearson's correlation 
coefficient test. 
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Figure-19 Correlation of IL-10 with haemoglobin 
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Figure-20 IL-10 in different malaria categories 
 
Table-28 Comparison of IL-10 in UM & SM categories 
P 
value 
Mean ±SD NumberSM categories UM 
0.421 213.80±91.53 13 Cerebral malaria 237.71±88.05 
0.032171.73±95.51 13Severe anaemia 
0.204 205.56±94.46 23 Repeated 
convulsions 
 
0.588 286.70 1 Hypoglycemia  
0.197147.95±193.53 2Haemoglobinuria 
0.910 242.85±37.14 4 Mixed 
presentation 
 
Shaded box indicate significance 
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Table-29 Correlation of IL-10 with clinical and laboratory parameters  
Parameter P value
Age 0.492
Sex 0.299
Hepatomegaly 0.728
Splenomegaly 0.270
Period of illness 0.051
Temperature 0.051
Parasitemia 0.072
Hb 0.016
RBG 0.224
Insulin 0.406
C-peptide 0.946
TWBCs 0.277
Total bilirubin 0.204
Direct bilirubin 0.467
Indirect bilirubin 0.211
AST 0.356
ALT 0.778
ALP 0.923
Urea 0.910
Creatinine 0.690
Sodium 0.860
Potassium 0.044
TNF-α 0.879
IFN-γ 0.104
Outcome 0.407
Shaded boxes indicate significance 
 
Correlation of cytokines with age 
No significant correlation was found between age and the mean cytokines 
levels but when children were grouped into those below and above 5 
years significant difference were detected in TNF-α and  IFN-γ. 
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Figure-21 TNF-α in children below and above 5 years 
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Figure-22 IFN-γ in children below and above 5 years 
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Table-30 Cytokines in children below and above 5 years 
cytokine Below 5 years Above 5 years P value
TNF-α 302.94±889.63 108.32±236.42 0.045
IFN-γ 3.54±8.59 5.20±10.24 0.034
IL-10 215.75±83.54 213.41±101.19 0.211
Shaded boxes indicate significance 
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CHAPTER FOUR 
DISCUSSION 
Introduction 
Severe malaria is a major health problem in Africa despite efforts 
directed toward its control. Children below 5 years are the main victim of 
severe malaria. The pathophysiological mechanisms underlying severe 
malaria manifestations are not well known. The aim of this study is to 
shed light on it so as to identify indicators of increased morbidity and 
mortality. 
The discussion will be mainly concerned with the serious complications 
of malaria recognised by WHO and the possible role and significance of 
cytokines in their pathogenesis. The effect of age on clinical categories of 
malaria and the cytokines response will also be taken in consideration.   
Effect of age on severity of malaria 
The mean age of children with severe malaria in this study was 56 
months. The mean age of children with uncomplicated malaria was 82 
months and a significant difference was found (P value=0.001). Children 
with severe malaria came from areas considered holloendemic for 
malaria. A study carried in Nigeria revealed 89.1% of children with 
severe malaria aged less than 5 years (242). Modlano et al (1998) 
conducted a study in Burkina Faso compared the age and clinical 
presentation of severe malaria between urban and rural areas, detected 
that children came from urban areas had a higher mean age than those 
came from rural areas (4.8 years versus 2.2 years). Children from rural 
areas had severe anaemia as the predominant manifestation while those 
from urban areas had CM (243).  
 
In highly endemic areas (spleen rate in children from 2-9 years more than 
50%) severe malaria tends to affect children younger than 5 years while 
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older children and adult tend to have the uncomplicated malaria (7). In 
low endemic areas (spleen rate in children 2-9 years less than 50%) 
severe malaria affects older children as well. Age is also relevant to the 
spectrum of severe malaria; severe anaemia and repeated convulsions are 
more prevalent in children below 5 years while cerebral malaria tends to 
affect older children (9, 149). 
 
In this study children with severe anaemia and repeated convulsions were 
younger than those with cerebral malaria. This finding is in agreement 
with another study conducted by Reyburn et al (2005) in Tanzania aimed 
to describe the clinical manifestations and fatality of severe malaria at 
different transmission levels. It reported that age and level of exposure 
independently affect the clinical manifestation of severe malaria (244). 
  
The differences caused by rate of transmission and age on the clinical 
picture of malaria can be explained by the time of acquisition of 
immunity. Immunity against malaria develops slowly with increasing age 
(245). As immunity developed, episodes of severe malaria decreased but 
still hyperparsitemia is frequent in older children. In adults parasitemia 
decreased and symptoms become few to absent.  
 
Age has a prognostic value. In the study age was found to correlate 
negatively with outcome (P value=0.018). Children with increased 
morbidity and mortality were less than 5 years (39& 30months 
respectively). This is in agreement with other studies which detect young 
age as indicator of poor prognosis (243, 246).  
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Anaemia in severe malaria 
The parasite lives in red blood cells, replicates and at the end the 
schizonts rupture and destroy the RBC. Anaemia correlates with the 
degree of parasitemia and duration of the acute illness (155, 156). 
Immune system- mediated destruction also reported in malaria (158, 159, 
160). Our findings support that hyperparasitemia was negatively 
correlates with Hb level and the duration of illness. 
 
In the study, children with severe malaria had a significantly lower Hb 
level than those with UM (7.5 versus 9.9). Children with severe anaemia, 
mixed presentation and those with CM had significantly lower Hb in 
comparison with children having UM. 
 
The pathogenesis of anaemia in severe malaria is multifactorial. RBCs 
destruction, suppression of erythropoeisis and cytokines are supposed to 
play a role in SA pathogenesis. 
 
About 38.5% of children with severe anaemia were hyperparasitemic but 
only 2% of them had elevated bilirubin of indirect type which can be 
taken as indirect measure of RBCs destruction. This discrepancy can be 
explained by suppression of erythropoeisis by parasite- derived factors.  
Erythropoeisis suppression is apparent in the study by absent or 
inappropriate reticulocytosis in 15% of cases of SA. Erythropoeisis 
suppression by haemozoin was reported in malaria (173, 174).  
Haemozoin was found to inhibit erythroid development in vitro. In 
children with malarial anaemia, the proportion of circulating monocytes 
containing hemozoin is found to be associated with anaemia (173). 
Haemozoin mediates bone marrow suppression directly and through NO 
induction. Keller et al (2004) conducted a study in Gabonese children 
found peripheral mononuclear cells obtained from children with malaria 
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produce higher NO than healthy children and NO inversely correlated 
with Hb level (174). NO was found to suppress erythropoiesis (175) and 
to induce apoptosis in erythropoietic precursors (176). 
  
Suppression of erythropoeisis by the cytokine TNF-α is another way of 
development of severe anaemia in malaria. TNF-α was found to suppress 
bone marrow function (180) and induce erythrophagocytosis (247). The 
suppressive effect of TNF-α on erythropoeisis may be mediated through 
NO. A study conducted by Maciejewski et al (1995) show that exposure 
of normal human bone marrow to NO result in inhibition of colony 
formation. NO induced apoptosis in bone marrow progenitors, as shown 
by electrophoretic detection of DNA degradation and deoxynucleotidyl 
transferase assay. Addition of IFN-γ or TNF-α increased inducible NOS 
mRNA and inducible NOS protein in bone marrow suggesting that NO 
may be one mediator of cytokine-induced hematopoietic suppression 
(248). In children with severe anaemia, TNF-α was found to be high 
(181). On the other hand, IL-10 may counteract the suppressive effect of 
TNF-α on the bone marrow by decreasing the production of TNF-α and 
stimulation of erythropoeisis (91). Children with severe anaemia had low 
IL-10(82, 182). 
 
In This study children with severe malaria were found to have low IL-10 
in comparison with UM. This is in accordance with other studies (82, 
182). However, TNF-α was low in this group which did not agree with 
above mentioned studies but it is in line with another study that reported 
low level of TNF-α in children with severe anaemia (249). 
 
IFN-γ values were found to correlate with Hb and the lowest values IFN-
γ values were found in children with severe anaemia. IFN-γ prevents 
hepatocytes invasion by the parasites and thus decrease subsequent 
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development of erythrocytic stage (202, 203). It also stimulates the 
infected hepatocytes to produce NO which mediates intracellular parasite 
killing (250). Protection against anaemia may relate to decreased 
hemolysis and bone marrow suppression associated with episodes of 
clinical malaria. John et al (2004) assessed the IFN-γ response of 
peripheral blood mononuclear cells obtained from children residing in a 
holloendemic area in Kenya to LSA-1and its relationship to clinical 
episodes and the development of anaemia. The study revealed a 
significant association between IFN-γ responses and protection against 
clinical malaria and anaemia (251). 
  
A study carried in Kenya proposed that IFN-γ production can be used as a 
potential marker of protective immunity against malaria associated 
anaemia in young children living in holloendemic areas (187). Our 
findings strongly confirm the finding of this study. 
 
Severe anaemia was not associated with mortality and this may be related 
to blood transfusion which is the current treatment for severe anaemia. 
However, combination of severe anaemia with other malaria 
complications was found to increase morbidity.  Another study detected 
increased mortality of severe anaemia when it was combined with 
respiratory distress or cerebral malaria (153). 
 
Liver involvement in severe malaria 
 
Liver pathology occurring during malaria infection is associated with the 
erythrocyte stage of the disease, although merozoites are not capable of 
infecting liver parenchymal cells. In contrast, infection of liver cells by 
sporozoites during the liver stage only leads to asymptomatic changes. 
This could be explained by the fact that during the erythrocyte stage, liver 
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and spleen are confronted with large amounts of infected erythrocytes and 
also free merozoites leading to a strong inflammatory response 
accompanied by the production of IL-12 and IFN-γ.  Jacobs et al (2004) 
conducted a study on mice revealed that during infection T cells were 
accumulated in the liver parenchyma which was associated with an 
inflammation as indicated by elevated levels of liver enzymes (252). The 
pathology was found to be dependant on production of IL-12 and IFN-γ. 
CTLA-4 expression, a down regulator of T cells function, is induced on 
CD4+ T cells during the erythrocyte stage of malaria in humans as wells 
as in mice. Anti CTLA-4 antibody treatment leads to enhanced liver 
pathology and increased IFN-γ secretion. In addition kupffer cells and 
sinusoidal endothelial cells release IL-10 upon stimulation with 
lipopolysaccharides leading to down regulation of the proinflammatory 
response (253). 
 
Hepatomegaly is common in children living in endemic areas. It is due to 
reticuloendothelial and lymphoid hyperplasia. However symptoms 
attributable to liver involvement in malaria were relatively uncommon 
(254) although elevation of liver enzymes was reported and malarial 
hepatopathy is now a recognized complication of malaria (255). It 
describes hepatic dysfunction in severe malaria and it is characterized by 
rise in serum bilirubin together with rise in serum transaminases 2-3 
times above normal levels. The bilirubin is of the conjugated type and 
bilirubin level is usually more than 10mg/dl. 
 
Bhave et al (2005) conducted a study in a tertiary hospital in Bombay and 
found an elevation of liver enzymes in 20% of patients with malaria 
(256). Anand et al (1992) detected jaundice in 39 patients and malarial 
hepatitis in 18 of them as indicated by a rise in their serum glutamate 
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pyruvate transaminase levels to more than three times the upper limit of 
normal and an absence of clinical or serological evidence to suggest drug 
or viral hepatitis. The liver in these patients was consistently enlarged. 
Liver histology showed Kupffer cell hyperplasia and deposition of 
malarial pigment. Plasmodium falciparum was demonstrated in 
sinusoidal red blood cells in only 2 cases (257). Another study revealed 
swollen hepatocytes, malarial pigment deposition, inflammatory 
infiltrates, congestion of hepatocyte and centrizonal necrosis along with 
elevation of transaminases in cases of malaria and jaundice (258).  
 
In this study no significant differences were found between transaminase 
levels between UM and SM, however children with SM had a 
significantly higher frequency of high levels of these enzymes which 
were 1-2times above normal level. The conjugated bilirubin was not 
elevated so jaundice in the severe malaria children can not be attributed to 
liver dysfunction but most probably to haemolysis of the RBCs. 
 
Further analysis of the data on liver functions and its relationship to 
cytokines was carried out and multiple regression models identified 
significant association between IFN-γ and ALP while TNF-α correlate 
positively with ALT. These findings suggest a possible role of these 
cytokines in the mediation of liver inflammatory process described by 
other studies. The mild liver inflammation in this group may also help 
explain the normal homeostatic regulation of glucose. 
 
 Bilirubin: In this study children with SM had significantly mild 
elevation of serum bilirubin than those with UM. It is mainly of 
unconjugated type. Children with increased morbidity and mortality had 
significantly higher serum bilirubin than those who had good outcome. 
Positive correlation was detected between bilirubin and urea and 
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creatinine (P value=0.000, 0.001 respectively) which may indicate 
contribution of hyperbilirubinemia to renal impairment within this group.  
  
Hyperbilirubinemia of the unconjugated type usually result from 
haemolysis. Destruction of parasitized and non parasitized RBCs was 
known to occur in malaria. The parasite lives in red blood cells, use 
haemoglobin for their growth and replication and at the end schizonts 
rupture and destroy their erythrocyte host cells. Increased 
erythrophagocytosis was also reported in malaria and it is mediated by 
immunoglobulin and the complement system (158, 159, 160).  
 
Presentation varies from mild jaundice to severe form with coma, renal 
failure and in some cases even hemorrhagic manifestations (259). It is 
only in this setting that jaundice signified a severe disease as noted by the 
World Health Organization action program. Marsh et al (1995) reported 
the presence of jaundice in children with malaria was one of serious 
prognostic factors (153). In this study, both serum bilirubin and liver 
enzymes indicate mild liver involvement 
 
Spleen in severe malaria 
 
The splenomegaly is usual in malaria and is often used as an 
epidemiological index of malaria transmission. Histologicaly both white 
and red pulp are expanded with reticuloendothelial and lymphoid 
hyperplasia, pigment deposition and sinusoidal dilatation (260). The 
spleen is considered the major site of parasite removal  and splenic 
function is increased in acute malaria. Parasite clearance is delayed 
considerably in splenectomized patients (261). The spleen has a capacity 
to remove intraerythrocytic parasites leaving the host erythrocyte intact, a 
process known as biting which result in parasite clearance without 
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destruction of RBCs consequently prevent a decrease in Hb. Angus et al 
(1997)conducted a study in Thailand with the aim of detection of pf155 
or ring erythrocyte surface antigen (RESA), which is expressed 
immediately following merozoite invasion  as a measure of parasitization 
and correlated this with the presence of intraerythrocytic parasites. 
During acute falciparum malaria infection RBC containing abundant 
ring-infected erythrocyte surface antigen (Pf 155 or RESA), but no 
intracellular parasites, are present in the circulation. This indicates that in 
acute falciparum malaria there is active removal of intraerythrocytic 
parasites by a host mechanism in vivo (probably the spleen) without 
destruction of the parasitized RBC (154). 
 
Chotivanich K et al (2002) found in acute malaria, RBCs that have been 
parasitized, but no longer contain a malaria parasite in the circulation. 
These are thought to arise by splenic removal of dead or damaged 
intraerythrocytic parasites and return of the intact RBCs to the circulation 
as 5 patients with acute falciparum malaria who had previously 
undergone splenectomy, circulating RESA-RBCs were absent in contrast 
to the uniform finding of RESA-RBCs in all patients with acute malaria 
and intact spleens. These observations confirm the central role of the 
spleen in the clearance of parasitized RBCs (262). 
  
In this study splenomegaly occurred in 21.4% of children with severe 
malaria. Splenomegaly was found to correlate negatively with 
parasitemia and positively with Hb indicating that biting process may be 
the sole mechanism of parasite removal by spleen. IFN-γ correlated 
positively with splenomegaly and with haemoglobin indicating that IFN-γ 
may prevent the decrease in haemoglobin level through induction of 
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splenomegaly and hence enhance spleen parasite clearance capacity and 
reduce parasitemia. 
   
TWBCs 
High TWBCs counts can result in increased WBCs sequestration in the 
brain vessels which is one of the known theories of the pathology of CM. 
Depletion of alpha and beta lymphocytes protects against CM (102). 
Depletion of T regulatory cells in mice prevented the development of 
CM. The mice had reduced number of active CD4 and CD8 T cells in the 
spleen and lymph nodes with selective reduction of CD8 T cells in the 
brain suggesting T regulatory cells contribution to pathogenesis of CM by 
modulating the immune response (106). 
In this study children with severe malaria had significantly higher 
TWBCs count than those with UM. CM, repeated convulsions and mixed 
presentation had significantly higher TWBCs count. Children with 
increased morbidity and mortality had high TWBCs count. This is in 
agreement with study carried by Maitland et al (2005) in Kenya found 
that children with fatal outcome had significantly higher WBCs count 
than survivors and they were frequently unconscious (213). Ladhani et al 
(2002) found leucocytosis was associated with both severity and 
mortality in children with falciparum malaria (263). 
Monocytes adhered to the vascular endothelium was found to be 
associated with loss of astrocyte ensheathment of vessels and increase in 
BBB permeability that occurs at the time of neurological complications in 
the murine models of malaria suggesting that toxic products produced by 
monocytes might play a role in astrocyte degeneration (264). 
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Blood glucose homeostasis 
 
The pathophysiology of malarial hypoglycemia in not well understood. 
Combinations of reduced endogenous glucose production and increased 
peripheral uptake of glucose were reported as possible causes (265). 
Unexplained impairment of gluconeogenesis in the presence of sufficient 
precursors was detected by a study on the payhophysiology of 
hypoglycemia in African children. The concentration of alanine, lactate 
and glycerol in children with hypoglycemia were not different from those 
without hypoglycemia (196). A study conducted in Khartoum Peadiatric 
Hospital (2009) detected high incidence of higher levels of gluconeogenic 
amino acids were associated with low RBG in hypoglycemic patients 
suggesting impaired gluconeogenesis (266). In contrast, Dekker et al 
(1997) conducted a study in children admitted to Kilifi District Hospital 
detected efficient gluconeogenesis which responded well to alanine 
infusion and proposed in severe malaria there is limitation in 
gluconeogenic precursors (200).   
 
Although the RBG of children with SM in this study was within the 
normal physiological range (89.27mg/dl), it was significantly lower in 
this group than in children with UM. Hypoglycemia was an infrequent 
complication of falciparum malaria found in only 7% of cases of severe 
malaria. This is in agreement with another study conducted in Khartoum 
Hospital which revealed that hypoglycemia occurred in 4.4% of patients 
with severe malaria (266). A study carried in Gabonese children aimed to 
describe clinical and laboratory features of severe malaria found that 
hypoglycemia accounted for 6.2% of severe malaria cases (9). It also 
detected hypoglycemia, coma and hyperlactatemia as predictors of a poor 
outcome and the fatality rate increased in children with the three features. 
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In this study children with mixed presentation had lower blood glucose 
concentrations than children with UM as well as a prolonged course of 
the disease with increased hospital stay.  On the other hand, children with 
hypoglycemia as the only presentation had short duration of illness and 
good outcome when managed by a protocol consisting of administration 
of 50% glucose and serial blood glucose monitoring. 
 
Cytokines and hypoglycemia: Several workers linked cytokines to the 
pathogenesis of hypoglycemia. TNF-α was found to be high in children 
with hypoglycemia (191, 196, 200).  
 
In this study children with hypoglycemia had the lowest TNF-α level 
which did not agree with the above studies. Moreover, TNF-α was found 
to positively correlate with RBG but correlation was not significant. The 
mean level of TNF-α in UM was 238.91pg/dl and RBG 108mg/dl. In 
severe malaria, the mean level of TNF-α was 178.52pg/ml and RBG 
89.27mg/dl. TNF-α has been reported to be associated with decreased 
insulin secretion and increased peripheral resistance to insulin (25, 26); 
thereby it may well be a factor in the modulation of blood glucose in 
severe malaria. Mice with induced cerebral malaria with plasmodium 
berghei infection had significantly high blood glucose when TNF-α levels 
were high. Administration of recombinant TNF-α to normal mice caused 
an increase in blood glucose. Mice transgenic for human TNF-α did not 
develop hypoglycemia when infected with plasmodium yolli but showed 
signs of insulin resistance (196).  
 
Feinstein et al (1993) examined the effects of TNF-α on the early events 
in insulin signaling pathway (267). He found that TNF decreased insulin-
induced phosphorylation of both beta subunit of the insulin receptor and 
IRS-1, the major insulin cytosolic substrate. These changes were not 
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associated with any reduction in insulin binding. Moreover, TNF-α was 
found to inhibit the suppressive effect of insulin in hepatic glucose output 
in experiment conducted by Lang et al (1992) involved infusion of TNF-α 
in rats followed by infusion of insulin and glucose to maintain 
euglycemia. Glucose infusion rate necessary to maintain euglycemia was 
found to be 30% lower in TNF-α treated rats, indicating an insulin-
resistant condition. This resulted from an impaired ability of insulin to 
both suppress hepatic glucose production and stimulate peripheral 
glucose uptake (25).  
 
In this study IFN-γ was found to have a significant positive correlation 
with RBG and children with hypoglycemia had low level of IFN-γ. 
Negative correlation was found between period of illness and IFN-γ as 
well as with RBG indicating that early production of IFN-γ is necessary 
to counteract hypoglycemia.  IFN-γ was found to decrease development 
of high density parasitemia and clinical malaria episodes (251). This may 
be caused by IFN-γ prevention of hepatocytes invasion and promotion of 
parasite killing within the hepatocytes. Schofield et al (1987) found that 
addition of IFN-γ to a hepatoma cell line invaded by malaria sporozoites 
lead to inhibition of parasite replication. The hepatoma cell line expressed 
IFN-γ receptors indicating that IFN-γ exerts its antimalarial activity 
by binding to surface receptors on hepatocytes and inducing 
intracellular changes unfavorable for parasite development (202). IFN-γ 
responses to liver stage antigen-1 (LSA-1) are thought to mediate this 
protection through induction of the nitric oxide pathway (268). In this 
study children with higher levels of IFN-γ were found to have low 
parasite densities. Positive correlation of IFN-γ was found with 
hepatomegaly and splenomegaly which enhance their parasite clearance 
capacity.  IFN-γ was also found to have minor endocrine and metabolic 
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activities as it stimulate ACTH and cortisol secretion therby elevates 
blood glucose (201). It is apparent that IFN-γ may elevate the blood 
glucose through different mechanisms.  
 
Parasitemia and hypoglycemia: Parasitemia was found to correlate 
negatively with RBG in this study. The frequency of hyperparasitemia 
was more in children with severe malaria than those with UM (30.4% 
versus 19.4%). Children with hypoglycemia and mixed presentation had 
higher frequency of hyperparasitemia than other severe malaria 
categories. It is well known that parasites use host blood glucose as a 
source of energy. Intraerythrocytic stages of malaria have a direct access 
to the plasma constituents through RBCs membrane pores and do not 
store glycogen or other reserve polysaccharides but depend on continuous 
supply of glucose from the host to continue the process of growth and 
replication (269). Suspensions of P .falciparum and P. vivax infected 
erythrocytes require the addition of glucose for parasite maintenance in 
vitro (270). Addition of glucose to P. vivax-infected cells increased the 
survival of the parasite (195). The plasmodia express a hexose transporter 
in their cell membranes. This transporter has a high affinity for glucose 
which maintains continuous supply of energy fuel to the parasites even 
when hypoglycemia complicates malaria (193). Parasitized erythrocytes 
consume up to 75times more sugar than their uninfected counterparts. 
The amount of glucose utilized is proportional to the degree of 
parasitemia (271).  
 
Looking to the above findings and the suggested mechanisms of 
hypoglycemia by this study and others previous work, indicates that 
hypoglycemia in malaria results from different dependant and 
independent mechanisms acting together. Better understanding of these 
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mechanisms will allow development of drugs that can ameliorate 
hypoglycemia. Targeting parasite colonization mechanisms of the RBCs 
and parasite hexose transporter, may be a promising field for developing 
a new generation of drugs. 
Insulin and C-peptide 
Kawo et al (1990) detected that children with hypoglycemia had 
appropriately low insulin and C-peptide when compared to 
normoglycemic children (272). Dekker et al (1997) conducted a study in 
children with acute falciparum malaria admitted to Kilifi District Hospital 
(Keya) detected appropriately low insulin level in children with 
hypoglycemia (191). In this study no significant differences in mean 
insulin, C-peptide and I/C ratio were found between uncomplicated 
malaria and severe malaria. Children with hypoglycemia had insulin level 
in the lower limit of the physiological range.  
 
Some studies, however, revealed that hyperinsulinemia is the cause of 
low blood glucose levels (195, 196). Elased et al (1994) carried a study in 
mice detected hyperinsulinemia at times of hyypoglcemia and 
dministration of diazoxide, insulin secretion inhibitor prevents 
development of hypoglycemia indicating the role of hyperinsulinemia in 
pathogenesis of hypoglycemia (195). Insulin secretion is stimulated 
directly by molecules derived from the parasite (195, 199) or it may 
complicate the treatment of children who receive quinine. Krishna et al 
(1994) detected that treatment with quinine was associated significantly 
with more episodes of post-admission hypoglycaemia when compared 
with artemether or chloroquine (188). Hyperinsulinemia was linked to 
quinine administration as detected by a study carried by White t al (1983) 
in eastern Thialand who detected inappropriate elevation of plasma 
insulin and C-peptide and a significant correlation between insulin and 
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quinine at the time of hypoglycemia (273). Quinine was found to 
stimulate insulin secretion, a finding came from a study carried by 
Agbenyega et al (2000) (198). 
 
Our work confirms appropriate insulin response to hypoglycemia. 
However children with severe malaria had lower insulin value when 
compared to expected value indicating loss of the circulating insulin 
which may be result from immunologically mediated destruction or 
excessive loss through the kidneys which may result from the 
hyperdynamic circulation. Those with mixed presentation had 
significantly higher C-peptide level and lower I/C ratio than children with 
other malaria manifestations which may be explained by decreased 
insulin half life or decreased renal excretion of C-peptide within this 
group. 
Disturbances of electrolytes and renal functions 
Sodium: Hyponatremia was significantly more frequent in severe malaria 
(62.5%) compared to uncomplicated malaria (48.4%) A study carried on 
Kenyan children detected hyponatremia in 53% of children with SM. 
Hyponatremia was not related to peripheral parasite density, dehydration 
and abnormal renal function. ADH was found to be inappropriate to the 
degree of dehydration (217). Another study found increased urine sodium 
concentration and low osmolality in children with hyponatremia. The 
levels of ADH in these children were inappropriately high (218).   
 
The present study reports hyponatremia, hypokalemia and low creatinine 
level in children with SM. These findings provide indirect evidence of 
inappropriate ADH secretion in severe malaria. No correlation was 
detected between the sodium level and degree of parasitemia. 
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Renal impairment was detected as contributor to hyponatremia in malaria 
(220, 274). Hyponatremia was found to be associated with increased 
urinary sodium concentration in the presence of reduced creatinine 
clearance in these patients (220). In this study no correlation was found 
between sodium and renal impairment so it is unlikely to be the cause of 
the hyponatremia reported above, however studies especially designed to 
investigate renal involvement may throw light on the mechanism of 
hyponatremia.  
 
Potassium: Alteration in potassium is associated with acidaemia and 
alkalemia. A study carried in thirty-eight Kenyan children with severe 
malaria and acidosis detected that at admission, serum potassium was 
normal in 31 (81.6%), low in 4 (11%) children and 3 (6.3%) children had 
hyperkalaemia. Plasma potassium decreased rapidly after correction of 
acidosis. Fractional excretion of potassium and the transtubular gradient 
of potassium were above normal range, indicating renal potassium loss 
and study concluded that hypokalaemia is a common complication of 
severe malaria; however, it is often not apparent on admission but after 
correction of acidosis, plasma potassium decreases precipitously and thus 
serial monitoring of serum potassium is suggested in patients with severe 
malaria complicated by acidosis (216). 
 
In the present study incidence of hypokalaemia is more frequent in 
children with SM than in those with UM. On the other hand 
hyperkalaemia was detected in 10.7% of children with SM and associated 
with increased risk of mortality. The death occurred in the first day of 
admission. It was more frequent in children with neurological 
manifestations.  Changes in potassium levels in 56 Kenyan children (42 
who survived and 14 who died) admitted to the hospital with clinical 
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features of severe malaria (impaired consciousness or deep breathing) 
complicated by acidosis,  showed that  hyperkalaemia complicated 
falciparum malaria in 9 children (16%), of  whom 7 (78%) died, 
generally soon after admission (213).  
 
In this study IL-10 was found to negatively correlate with potassium 
level. The stress of infection is known to activate the hypothalamic 
pituitary adrenal axis which results in increase cortisol secretion (275, 
276). This is also reported in malaria (277, 279). On the other hand, the 
stress axis plays a significant role in regulating IL-10 expression. 
Inflammation of the central nervous system and endotoxaemia triggers 
the release of IL-10 in the circulation through activation of the stress axis 
(276, 279). This study states that activation of the stress axis during 
plasmodium infection may explain the relation between IL-10 and 
potassium observed in the study.  
Urea: Mild renal impairment is common in children with both 
complicated and uncomplicated malaria (280). Dehydration which was 
known to occur in malaria leads to acute renal tubular degeneration. 
Renal impairment is indicated by increased urea and creatinine 
concentrations (274, 280). 
 
The present work shows that mean urea levels were nearly the same in 
SM and in UM. But children with mixed presentation had a significantly 
higher urea level than those with UM. This group of children had 
hyperbilirubinemia and a positive correlation was found between urea 
and creatinine with bilirubin indicating role of hyperbilirubinemia in the 
pathogenesis of renal impairment. This group of children had increased 
morbidity. Abdul manan et al (2006) found the presence of disseminated 
intravascular coagulopathy, cerebral malaria or hyperbilirubinemia in 
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patients with renal impairment were associated with poor prognosis 
(281). In the study children with mixed presentation in addition to the 
high urea and hyperbilirubinemia they had leukocytosis, low Hb and low 
RBG. 
 
Acute renal failure is seen mostly in Plasmodium falciparum infection, 
but P vivax and P. malariae can occasionally contribute to renal 
impairment (280, 281). Malarial ARF is commonly encountered in non-
immune adults and older children with falciparum malaria in areas of low 
endemicity. Several hypotheses including mechanical obstruction by 
infected erythrocytes, immune mediated glomerular and tubular 
pathology, fluid loss due to multiple mechanisms and alterations in the 
renal microcirculation have been proposed (209, 212, 207, 281).  
Creatinine: In this study creatinine was found significantly lower in 
children with SM than in those with UM. This finding can be explained 
by the inappropriate ADH secretion which was reported to occur in SM 
and supported by the study. 
Children with mixed presentation were found to have a relatively high 
creatinine in comparison with UM and other SM categories. This group 
of children had higher urea and relatively higher sodium in comparison 
with UM and other SM categories. They also had higher body 
temperature, higher incidence of tackycardia and tackypnoea than UM 
and other SM categories. These findings suggest that dehydration may 
play a role in this subgroup of SM and that dehydration is an indicator of 
poor outcome in children with SM. Thus volume resuscitation should be 
considered in severe malaria with evidence of dehydration. Maitland et al 
(2003) conducted a retrospective study in Kenya detected dehydration in 
57% of children with SM. About 17.5% of these children died while only 
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7% of those without dehydration died (282). Maitland et al (2003) found 
that volume expansion in children with dehydration was associated with 
correction of the haemodynamic abnormalities and improvement of organ 
functions (283). 
 
Haemoglobinuria 
 
Two children in the study were found to have mild haemoglobinuria. 
They had no anaemia, jaundice or renal failure at admission but one of 
them developed jaundice in the ward. Massive haemoglobinuria is 
encountered rarely during the course of malaria. In this situation it can be 
accompanied by anaemia, acute renal failure and jaundice (226). 
 
The haemoglobinuria in malaria is found to be related to quinine therapy.  
A study in African children report three cases of haemoglobinuria in 
children who repeatedly had malaria infection and quinine treatment 
(222). It is commonly encountered in Europeans living in Africa who take 
quinine irregularly (227). In this study one child had a history of an attack 
of malaria 2 weeks before admission and administration of quinine. 
 
Parsitemia was found to be scanty or absent in haemoglobinuria (271). In 
the study parasitemia level was lower in haemoglobinuric patient than in 
other malaria categories. 
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Cytokines in severe malaria 
 
The balance between pro- and antiinflammatory cytokines may be 
important in malaria presentation and outcome. Malaria tends to be more 
severe in children than in adults, because immunity develops with age. A 
number of cellular proinflammatory type 1 cytokines were significantly 
higher in all children (with or without malaria) than in all adults; these 
include the percentages of various lymphocyte populations making IL-6, 
both IL-6 and IFN-γ, or IL-8 (285). Therefore the immune response to 
malaria seems to be more proinflammatory in children than in adults.  
Low levels of IL-12 and TGF-β1 contribute to increased disease severity 
in malaria and IL-12 and TGF-β1 have been reported to be significantly 
lower in children with severe malaria. TNF α and IL-10 however, were 
significantly higher in children with severe malaria. In contrast, ratios of 
TGF-β1/TNF-α and IL-10/TNF-α were significantly lower in the severe 
malaria group (286). These data suggest that the inflammatory cascade in 
severe malaria is characterized by suppression of the protective effects of 
TGF- 1 and IL-12, and that overproduction of TNF-α may promote 
deleterious effects, such as severe anaemia (286) and cerebral malaria 
(287).The best-documented evidence implicates IFN-γ, TNF-α and IL-12 
in the pathogenesis of CM (288) and a protective effect has been 
demonstrated for IL-10 (287)  
  
A study on mice showed that the parasite induces expression of cytokines 
in the brain, liver and spleen which contribute to the pathological 
processes in these organs leading to differences in clinical features and 
lethal outcomes (289). Thèse cytokines are TNF α, IFN-γ, IL-1, IL-6, IL-
10 and IL-12. The higher levels are believed to be protective against 
infection. TNF-α and IFN-γ enhance clearance of parasitized cells by 
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phagocytosis (290). Intraperitoneal injection of mice with recombinant 
IL-12 appears to induce IFN-γ mediated protection against plasmodium 
yoellii sporozoite challenges (291). IL-10 inhibits production of TNF-α in 
response to malarial antigen, thus IL-10 appears to play an important role 
in counteracting the potentially harmful host proinflammatory response to 
malaria antigens (292). Alternatively cytokines may be involved in the 
manifestations of disease severity. Higher levels of IFN-γ, TNF-α, IL-1, 
IL-6, IL-10 and IL-18 are observed particularly in patients with severe 
malaria (293). TNF-α is known to be an essential element in the 
pathogenesis of cerebral malaria and severe malarial anemia (133, 91). 
Low IL-10 was found to be associated with severe anemia (82). The 
present study confirms the essential role of TNF-α in cerebral malaria as 
children with this complication had significantly higher TNF-α while 
children with severe anaemia had low IL-10. 
Certain cytokines levels were found to predict the outcome. TNF-α level 
in serum can predict a fatal outcome in cases of CM. Patients with CM 
who had fatal outcome had TNF-α concentrations in serum higher than 
those with uncomplicated malaria (81). The ratio of anti-inflammatory 
(IL-10) to inflammatory (TNF-α) cytokines in serum is found to be the 
best determinant of the outcome (294)  
In this study children aged less than 5 years in whom severe malaria 
predominate had higher levels of TNF-α when compared to those aged 
more than 5 years indicating essential role of  TNF-α in pathogenesis of 
severe malaria. Children with cerebral malaria had a significantly higher 
TNF-α than other severe malaria categories. IL-10 was lower in children 
with severe malaria in comparison to those who had uncomplicated 
malaria although not statistically significant. However, IFN-γ was found 
to have a significant role in mediation of immunity against malaria as 
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children with uncomplicated malaria tend to have higher levels of IFN-γ 
when compared to those with severe malaria while children above 5 years 
had higher IFN-γ than children less than 5 years. 
  
TNF-α  
TNF-α mediated immunity in malaria: TNF-α is produced by γδ T 
cells and NK cells in malaria during innate immunity. Early production of 
TNF-α is associated with protection (39). TNF- α has been shown to 
inhibit parasite survival in some rodent malaria models (295, 296). TNF-
α and IFN-γ act synergistically to optimize nitric oxide production which 
in turn leads to parasite killing (53). In humans TNF-α and nitric oxide 
levels are associated with resolution of fever and parasite clearance (57, 
58). TNF-α enhance human neutrophil killing of P. falciparum (295, 297, 
298). 
TNF-α mediated pathology in malaria: Excessive production of TNF-α 
was found to be associated with increased risk of severe malaria. Lyke et 
al (2004) working in Mali found higher TNF-α level in children with 
severe malaria than children with UM (299). Another study carried in 
Senegal detected similar finding and higher level of TNF-α was 
associated with fatal outcome (300). 
 
In this study the mean TNF-α level in children under 5 years was 
significantly higher when compared to those above 5 years. This finding 
is in accordance with the above literature that moderate levels of TNF-α 
are beneficial to the host and protect from severe disease while high level 
of TNF-α produce severe reaction which are damaging and predispose to 
severe malaria. 
  
TNF-α in CM: Excessive TNF-α production plays a critical role in the 
pathogenesis of CM. This is supported by an experimental study 
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conducted by Grau et al (1992) revealed high serum TNF-α was at the 
time of the neurological syndrome and Single injections of anti-TNF-α 
antibody ameliorate the cerebral complications (133). Kwiatkowski et al 
(1990) undertook a study involving 178 Gambian children and found that 
plasma TNF-α level in children that had survived CM were twice as high 
as normal levels. In the fatal cases they were 10-fold higher than normal, 
leading to the conclusion that excessive TNF-α production may 
predispose humans to CM and its fatal outcome (81). 
 
In situ hybridization shows an increase in expression of TNF-α mRNA in 
brain of mice with fatal cerebral malaria as early as day 3 post 
inoculation., which is several days before the onset of cerebral symptoms, 
although TNF-α protein was not detectable until at least day 5 post 
inoculation. At day 5 post inoculation small numbers of cells of microglia 
and astrocytes were positive for TNF-α protein. In addition, endothelial 
cells and monocytes adherent to the cerebral vasculature were also 
positive. At a time when the mice were showing severe cerebral 
symptoms at day 7 post inoculation there was a massive increase in the 
number of the above-mentioned cells positive for TNF-α protein (301). 
 
In both human and murine CM, the blockage of cerebral vessels by 
parasitized RBCs is thought to be caused by TNF- α mediated up-
regulation of adhesion molecules, such as intercellular adhesion molecule 
(ICAM)-1 on the endothelium (119, 131). 
 
In this study children with cerebral malaria had a significantly higher 
mean TNF- α than those without cerebral malaria which agrees with the 
above literature. 
TNF-α in anaemia: Higher levels of TNF-α in serum were found to be 
associated with severe anaemia. Ortho et al (1999) found TNF-α and IL-
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10 were significantly elevated in children with anaemia compared with 
children having UM and the highest concentrations of TNF-α were found 
in children with malaria anaemia. The mean ratio of IL-10 to TNF-α was 
significantly low in children with anaemia than in children UM (91). 
Thus, higher levels of IL-10 over TNF-α may prevent development of 
malaria anaemia by controlling the excessive inflammatory activities of 
TNF-α.  Kurtazhals et al(1998) found that the ratio of TNF-α to IL-10 
was significantly higher in fully conscious patients with severe anaemia 
than in children with CM and UM concluding severe malarial anaemia is 
a distinct disorder in which insufficient IL-10 response to high TNF-α 
concentrations may have a central role (82). 
   
In this study children with severe anaemia had low TNF-α which doesn’t 
agree with the above literature. The explanation of this finding may be 
related to period of illness in severe anaemia group (4.46days) which 
allow TNF-α to exert its suppressive effect and then down regulated by 
IL-10. Another alternative explanation is the presence in this group of 
children of TNF-α allele associated with low TNF-α production. Low 
level of TNF-α in children with severe anaemia was reported in the 
presence of TNF-238A allele suggesting that genetic factors may 
influence TNF-α in SA (249).  
IL-10 
IL-10 down regulates T helper 1 responses, namely IFN-γ and TNF- α 
secretion. A study in mice detected reduction in the amounts of 
lipopolysaccharide induced TNF-α release in the circulation after IL-10 
pretreatment. IL-10 was given to mice before lipopolysaccharide 
challenge (302). Murine and in vitro studies have demonstrated IL-10 
ability to inhibit TNF-α production in response to malarial antigens (303, 
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304). Thus, IL-10 appears to play an important role in counteracting the 
potentially harmful host proinflammatory response to malaria antigens. 
IL-10 is thought to protect against severe malaria complications. IL-10 
deficient mice infected with Plasmodium chabaudi suffer a more severe 
disease and exhibit a higher rate of mortality than control. The deficient 
mice showed a drop in body temperature to below 28°C and pronounced 
hypoglycemia. Elevated inflammatory responses have been shown to 
accompany pathology in infected IL-10 deficient mice. Neutralization of 
TNF-α in IL-10 deficient mice abolishes mortality and ameliorates the 
hypothermia, weight loss, and anemia but does not affect the degree of 
hypoglycemia. These data suggest that TNF-α is involved in some of the 
pathology associated with a Plasmodium chabaudi infection in IL-10 
deficient mice (305). In this study children with severe malaria had lower 
IL-10 than children with uncomplicated but it did not reach significant 
statistical difference. 
 
IL-10 in CM: IL-10 has a protective role against CM as it decreased 
TNF-α production. May et al (2000) conducted a study in Gabonese 
children found IL-10: TNF-α plasma level ratios <1 were a risk factor for 
both cerebral malaria and severe anaemia (294). During a Plasmodium 
chabaudi infection in IL-10 knockout mice, there is greater parasite 
sequestration, more severe cerebral edema, and a high frequency of 
cerebral hemorrhage compared with infection of C57BL/6 mice. Anti-
TNF-α treatment ameliorated both cerebral edema and hemorrhages, 
suggesting that proinflammatory responses contributed to cerebral 
complications in infected IL-10 deficient mice (145). Furthermore 
kossodo et al (1997) found anti IL-10 anti body administration to resistant 
mice induced CM in 35.7% of these mice while administration of IL-10 
to susceptible mice prevents the occurrence of CM (306).  
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One mechanism by which IL-10 prevents CM is through decreased 
platelet production. Platelets mediate a syndrome of cerebral malaria in an 
animal model of malaria infection (307). Histopathological studies of 
children who have died of severe malaria showed that platelet clumps 
with and without infected erythrocytes are frequently found in 
the vasculature (308). Infected erythrocytes may adhere to platelets, and 
the clumps of infected erythrocytes and platelets have been associated 
with severe disease (309). Platelets were found to accumulate in brain 
vessels of patients dying of CM and may play a role by providing 
adhesion receptors involved in sequestration (310). Casals –Pascaul et al 
(2006) studied the relationship between thrombocytopenia and cytokines 
in Kenyan children with severe malaria and showed that 
thrombocytopenia (platelet count < 150 x 109/L) strongly correlates with 
high levels of IL-10(311). 
 
In this study the mean IL-10was lower in CM when compared to UM but 
it did not reach significance. 
 
IL-10 in anaemia: Low level of this cytokine was linked to severe 
anaemia in children with malaria through inhibition of TNF-α production 
which was found to suppress erythropoeisis and mediate 
erythrophagocytosis. 
 
Kurtzhals et al (1998) compared IL-10 and TNF-α between children with 
severe anaemia, cerebral malaria and uncomplicated malaria. Children 
with severe anaemia had significantly low level of IL-10 than other group 
and the ratio of TNF-α to IL-10 was high in severe anaemia than others 
concluding that severe malarial anaemia is a distinct disorder in which 
insufficient IL-10 response to high TNF-α concentration may have a 
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central role (82). In accordance with this study, a study carried by ortho et 
al (1999) who detected that the ratio of IL-10 to TNF-α was significantly 
higher in children with mild and high-density parasitemia than in children 
with malaria anaemia postulating that higher levels of IL-10 over TNF-α 
may prevent development of malaria anemia by controlling the excessive 
inflammatory activities of TNF-α (90)Nussenblatt et al (2001) found that 
in older children higher levels of TNF-α were significantly associated 
with higher IL-10 levels unlike younger children who had low IL-10. 
These data suggest that younger children do not maintain IL-10 
production in response to the inflammatory process, and this mechanism 
may contribute to the more severe anemia found in younger children with 
malaria (312). 
 
In this study severe anaemia group had a significantly lower IL-10 when 
compared to children with uncomplicated malaria and to those without 
severe anaemia. Furthermore it is correlated with Hb. These finding 
agrees with the mentioned studies.  
 
In conclusion IL-10 is an important as anti-inflammatory cytokine in 
malaria counteracting the production and action of TNF-α in children 
with severe malaria. Genetic studies are highly recommended to explain 
the differences in the responses of children to the disease. 
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IFN-γ 
IFN-γ-mediated immunity in malaria: Most studies detect IFN-γ as the 
hallmark of immunity against malaria. Winkler et al (1999) investigated 
the type 1/type 2 dichotomy of T cells in patients of different age groups 
with acute P. falciparum malaria for the purpose of examining 
immunoregulatory mechanisms that ultimately result in different levels of 
antimalarial protection. He detected increased frequency of IFN-γ –
producing cells in adult compared to children and in children aged more 
than 5 years in comparison to those aged less than 5 years (42). This 
finding was confirmed by the result of this study as the mean IFN-γ was 
significantly higher in children aged more than 5 years when compared to 
those aged less than 5 years.  Furthermore IFN-γ production capacity of 
both CD8+ and CD4+ cells was positively correlated with aging Bucci et 
al (2000) conducted a study in children residing in Papua New Guinea 
compared IFN-γ response to three peptide epitopes of plasmodium 
falciparum liver stage antigen ( LSA) in different age groups. He detected 
that IFN-γ responses increased with age in malaria exposed subjects: 14–
16% and 30–36% of 2–5 and 6–54-year olds, respectively, had ≥10 IFN-
γ-secreting cells/106 peripheral blood mononuclear cells when stimulated 
with at least one peptide variant of LSA. IFN-γ responses to all three 
peptides were also greater for older than younger individuals. No children 
<3 years old had lymphocytes that responded to all three peptides, 
whereas 45% of adults (mean age 48 years) had aggregated IFN-γ 
responses (314). 
 
John et al (2004) postulate that IFN-γ responses to LSA-1 appear to 
require repeated P. falciparum exposure and/or increased age and are 
associated with protection against clinical malaria and anaemia (251). 
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IFN-γ is produced by γδ T cells and NK cells during innate immunity in 
malaria (38). Enhanced NK cell activity in spleens of mice infected with 
irradiated Plasmodium berghei sporozoites was detected (43). 
Plasmodium yoelii sporozoite infection has been shown to induce a rapid 
inflammatory response in the liver characterized by NK cell, macrophage, 
and T cell infiltration and IFN-γ production (44).  
Early production of IFN-γ was associated with protection from severe 
disease. Mice deficient in γδ T cells had exacerbated early and chronic 
parasitemia (38). Another study detected a marked heterogeneity in 
magnitude of NK IFN-γ response reflecting variation between host 
capabilities to mount rapid proinflammatory response which then affect 
their innate suscepatability to malaria infection and its complication (40).  
In this study as the incidence of high levels of IFN-γ was more frequent 
in uncomplicated malaria than in severe malaria. The mean IFN-γ in 
children above 5 years was significantly higher than those under 5 years.  
IFN-γ plays an important role in resistance to blood stage malaria 
infection as well. Activation of human macrophages with IFN-γ results in 
activation of phagocytic activity and killing of malaria parasites (89). 
Peripheral blood mononuclear cells from children with uncomplicated P. 
falciparum infection produce high levels of IFN-γ when stimulated in 
vitro with merozoite antigens and these children have a lower risk of re-
infection. In contrast, children with severe malaria show lower levels of 
IFN-γ production by Peripheral blood mononuclear cells and are more 
susceptible to re-infection (41). Mice defected in IFN-γ and its receptor 
show a predominantly Th2 response, which is associated with 
susceptibility to P. chabaudi infection (315, 316). Thus, IFN-γ is critical 
for resistance to blood stage malaria.  
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IFN-γ in severe anaemia: A study carried on Kenyan children with 
malaria examined IFN-γ responses to pre-erythrocytic stage antigens 
found that IFN-γ positive responders had higher haemoglobin levels and 
significantly reduced prevalence of severe malarial anaemia one month 
after the test compared with IFN-γ non-responders, suggesting that IFN-γ 
immune responses to these pre-erythrocytic antigens were associated with 
protection against malarial anaemia (187). The study proposed that IFN-γ 
production could be used as a potential marker of protective immunity 
against malaria associated anaemia in young children living in malaria 
holoendemic areas. IFN-γ induced the infected hepatocyte to produce NO 
which lead to killing of the intracellular parasite. This in turn leads to 
decrease in subsequent devoloping parasitemia. This study showed that 
IFN-γ correlate positively with haemoglobin. Children with severe 
anaemia had the lowest levels of IFN-γ. This indicates that high levels of 
the cytokine IFN-γ are needed to counteract anaemia. 
 
IFN-γ in CM: IFN-γ has essential role in CM pathogenesis as it 
augments both the production and action of TNF-α. Grau et al (1989) 
conducted a study in mice detected that administration of monoclonal 
antibodies against IFN-γ after infection prevented the development of 
CM together with reduction in TNF-α production (142). Furthermore 
Rudin et al (2005) found that IFN-γ receptor deficiency in  mice infected 
with Plasmodium berghei ANKA result in protection from CM. 
Plasmodium berghei ANKA -induced release of TNF-α and up-regulation 
of endothelial intercellular adhesion molecule expression, recruitment of 
mononuclear cells, and cerebral microvascular damage with vascular 
leakage occur only in wild-type mice not in mice with IFN-γ receptor 
deficiency. Resistance to CM in IFN-γ receptor deficient mice is 
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associated with reduced serum TNF-α level, reduced IL-12 expression in 
the brain and increased T-helper 2 cytokines (317).  
 
In this study no significant difference was found in IFN-γ between 
children with cerebral malaria and those with uncomplicated malaria and 
in those without cerebral malaria. 
Genetic profile 
Genetic profile was found to affect cytokines responses in malaria. Ouma 
et al (2008) studied the relation between common variation in IL-10 
promotor, circulating level of IL-10 and TNF-α and susceptibility to SA 
in Kenyan children. He detected that the -1,082G/-819C/-592C (GCC) 
haplotype was associated with protection against SA and increased IL-10 
production. Although none of the other haplotypes were significantly 
associated with susceptibility to SA, individuals with the -1,082A/-819T/-
592A (ATA) haplotype had an increased risk of SA and reduced 
circulating IL-10 levels. The IL-10: TNF-α ratio was higher in the GCC 
group and lower in individuals with the ATA haplotype. The study 
concluded that common IL-10 promoter haplotypes condition 
susceptibility to SA and functional changes in circulating IL-10 and TNF-
α level in children with falciparum malaria (313). May et al (2000) 
studied the association of allelic variants of the TNF promoter in children 
with severe malaria and IL-10: TNF-α ratio found that carriers of the wild 
type more frequently had an IL-10: TNF-α ratio >1. In contrast, 
individuals with a mutation at position 238 of the TNF-α promoter 
consistently had lower IL-10 than TNF-α plasma levels (IL-10: TNF-α 
ratio <1). These results show that, in children with severe malaria, TNF-α 
promoter variants influence the balance of IL-10: TNF-α in the plasma, 
which, in turn, affects the outcome in terms of clinical complications 
(294). 
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In this study significant difference was found in the mean TNF-α and 
IFN-γ between children with cerebral malaria and severe anaemia (P 
value=0.029 and 0.002 respectively) as well as in IFN-γ between severe 
anaemia and repeated convulsions (P value=0.010). Mcquire et al (1999) 
reported low level of TNF-α in children with severe anaemia while high 
levels were found in CM and TNF-238A allele was associated with SA 
suggesting that different genetic factors may influence CM and SA (249). 
Studies especially designed to link genetic profile with the different 
clinical presentation of malaria are recommended so as to identify 
children more likely to develop excessive inflammatory response and 
malaria complications. Genetic factors may also determine the receptor 
population for various cytokines, thus influencing the host response (85).  
 
Cerebral malaria  
CM was found to be associated with increased morbidity and mortality. 
This finding is in agreement with another study conducted by Issifou et al 
(2007) detected CM as an indicator of poor prognosis (318). In 89.6% of 
cases coma is preceded by convulsions and they are associated with poor 
outcome.  Molyneux et al (1989) examined the clinical and laboratory 
features of CM in 131 Malawian children detected convulsions at the 
time of admission, leucocytosis, hyperlactatemia and hypoglycemia to be 
associated with poor outcome (92). In this study children with CM had a 
significantly higher TWBCs count, higher bilirubin and lower Hb in 
comparison with those with UM. 
  
CM is encountered in older children who probably had acquired 
significant degree of immunity against malaria if they were residing in 
endemic areas (32). The mean age of children reported in this study with 
CM was 61 months. This suggests that CM is an immune system related 
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disease. Over production of cytokines TNF- α and IFN-γ causes many of 
the pathological features of CM. Sequestration of the parasitized RBCs 
and leukocytes in the cerebral microvasculature was reported as a cause 
of CM (110). A study carried in mice detected sequestration of 
parasitized RBCs and leukocytes in brain vessels was associated with 
increased expression of TNF-α and ICAM-1 in blood vessels (111). TNF- 
α upregulates adhesion molecules involved in parasitized RBCs and 
leukocytes sequestration within the cerebral microvasculature (119). High 
TNF-α in the serum was detected by many studies of CM (130, 133).  
 
Indirect evidence for parasite sequestration in this study can be deduced 
from comparing hyperparasitemia and bilirubin in CM and SA 
 
Severe malaria 
category
Hyperparasitemia(percentage) Bilirubin(mean in 
mg/dl)
CM (n=13) 61.5 1.162
SA (n=13) 61.5 0.892
 
The difference noted may be explained by the observation that the 
peripheral parasite count in CM is not a real indicator of parasitemia as 
the parasites are sequestered in brain. This finding is in accordance with 
another study carried by Seydel et al (2006) who measured the 
concentration of parasite-derived lactate dehydrogenase (pLDH) in tissue 
samples obtained at autopsy from patients with clinically defined cerebral 
malaria. There was no correlation between peripheral parasitemia and the 
measurement of pLDH in any of the tissue samples (319).  
 
Another mechanism by which TNF-α is supposed to cause CM is through 
reduction of cerebral blood flow. Reduced cerebral blood flow was 
detected by MRI at advanced stages of CM and result in neuronal damage 
as apparent from reduction in level of N-acetylaspartate (98, 320). 
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MRI study revealed that focal intrastriatal injection of TNF-α in mice 
leads to significant decreases in cerebral blood volume (320). Moreover, 
TNF-α facilitates the release of endothelin by endothelial cells (321). 
Endothelin is a potent vasoconstrictor and has a capability to increase 
blood brain barrier permeability which leads to cerebral edema and by the 
two mechanisms endothelin reduces cerebral blood flow (116, 322, 323). 
Excessive endothelin expression was found in brain of infected mice 
(103). 
Microglial cells activation is also reported in malaria. Studies carried in 
mice detected morphological changes in microglia consistent with their 
activation and redistribution toward blood vessels (140). The activated 
microglia through an excitotoxic mechanism have been suggested to 
cause the pathological and clinical feature of CM (141). Microglial cells 
activation was found to be induced by TNF- α (139). 
TNF- α was found to induce NO production (134). Increased expression 
of inducible nitric oxide synthase was found during acute CM in the 
neurons, microglial cells, astrocytes and in the macrophages surrounding 
ring hemorrhages (136). NO metabolites were found to be higher in 
plasma and the CSF of children with CM and associated with poor 
outcome (137, 65, 138). NO is known to affect synaptic transmission 
(135) and thus it may contributes to the developing seizures and coma. 
So TNF- α through different mechanisms which can act alone or in 
combination in a given individual may have a significant contribution to 
the pathological and clinical features of CM. 
High level of IL-10 is thought to be protective against CM development 
by inhibiting TNF-α production. IL-10 knockout mice infected with 
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plasmodium chabaudi develop greater parasitic sequestration and severe 
cerebral edema and hemorrhages and administration of anti-TNF 
ameliorate both cerebral oedema and haemorrhages (145).   
In this study significant difference was found in the mean TNF-α between 
children with cerebral malaria and those without cerebral malaria. 
Furthermore children with cerebral malaria had lower ratio of IL-10 to 
TNF- α when compared to those with uncomplicated malaria (0.99 versus 
0.82). This indicates that children with CM had lower IL-10 to balance 
the inflammatory effect of TNF- α.  
 
IFN-γ was found to augment the production and action of TNF-α. An 
experimental study in mice detected that administration of monoclonal 
antibodies against IFN-γ after infection prevented the development of 
CM and its associated histological feature. Monoclonal antibodies 
administration also resulted in decreased TNF-α production which leads 
to the conclusion that IFN-γ both augments the production and action of 
TNF-α (142). In this study although mean IFN-γ is higher in CM when 
compared to UM and other categories of SM, it was not statistically 
significant. 
 
Repeated convulsions 
Repeated convulsions represented 41% of cases of SM which was the 
most frequent complication of SM in this cohort. Children with this 
complication had a mean age of 56 months. A retrospective study 
conducted by Idro et al (2007) in Kilifi Hospital in Kenya reported 
seizures to be the most common neurological feature of acute falciparum 
malaria and were observed at admission in 37.5% of children. Seizures 
were not common before the age of 6 months. After 12 months, the age-
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specific prevalence increased rapidly reaching a peak prevalence of 
48.6% among patients aged 27 to 33 months (324). 
  
Repeated convulsions in malaria were found to indicate cerebral 
dysfunction rather than being febrile convulsions as no correlation was 
detected between fever and the incidence of repeated convulsions (150). 
Similar findings are reported in this study.   
Prolonged, multiple seizures complicate a high proportion of cases of 
childhood cerebral malaria lead to further deterioration in the level of 
consciousness. Repeated convulsions were found to contribute to both the 
morbidity and mortality (93).  In this study children with increased 
morbidity (three children with mixed presentation and one child with 
CM) and mortality (one child with CM) had repeated convulsions. 
However children with isolated repeated convulsions had a more 
favorable outcome. 
In the present study children with repeated convulsions were found to 
have significantly higher bilirubin and higher total WBCs count in 
comparison with UM. They had TNF-α level comparable to UM but 
relatively higher levels of IFN-γ. The conclusion that can be derived from 
these findings is that the mechanisms of CM may be the same mechanism 
of repeated convulsions. Period of illness before admission may 
discriminate the two. The mean period of illness in children with repeated 
convulsions was 1.61 days while in CM it was 2.23 days. Early 
presentation to hospital allows early antiparasitic therapy which is known 
to decrease cytokines level (199). Another factor may be the low parasite 
density which was observed in children having repeated convulsions in 
comparison to those with CM (17.4 versus 38.5). It appears that multiple 
factors are involved in the pathogenesis of repeated convulsions. This 
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indicates that future research should focus on single presentation so as to 
determine the pathophysiological mechanisms.   
Indicators of poor outcome 
Malaria is one of the major killers of children in Africa. About 94% of 
global deaths attributed to malaria occur in Africa (325). Despite the 
programmes of malaria control the incidence of mortality continues to 
rise (326). This is mainly attributable to the fact that the 
pathophysiological mechanisms of the disease is still not well known 
despite the huge literature which has not yet become reflected in the 
management protocols.  
Many studies tried to find indicators of severity of disease and markers 
for morbidity and mortality. The ultimate aim is to identify children with 
increased risk of higher morbidity and mortality and thereby offer these 
children intensive care taking into account the morbidity and mortality 
indicators. 
Marsh et al (1995) et al conducted a prospective study in the pediatric 
ward of a district hospital in Kenya detected mortality rate of malaria was 
3.5% and reported that 84% of the deaths occurred within 24 hours of 
admission. Key prognostic indicators were impaired consciousness, 
respiratory distress, jaundice and hypoglycemia (153). 
   
Dzeing- Ella et al (2005) examined the clinical and laboratory features of 
severe malaria in Gabonese children and found the prognostic indicators 
with the highest case fatality rates were coma/seizures, hyperlactataemia 
and hypoglycaemia and the highest case fatality rate was in children with 
all three of these features (9). 
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Another study in Tanzania detect hypoglycemia, respiratory distress and 
dehydration as indicators of increase risk of death (327) 
In this study multiple regression models identified severe malaria, 
cerebral malaria, mixed presentation and potassium as independent 
factors associated with increased morbidity and mortality. The mortality 
rate was 1.8% and death occurs within the first day of admission.  
Cerebral malaria: CM was found to predict both fatal outcome and 
morbidity. This is in accordance with another study conducted by 
Winkleret al (2008) in children which reported CM and respiratory 
distress independently associated with increased risk of morbidity and 
mortality (328). 
In this study hyperkalemia was found more frequent in children with 
neurological involvement than in other malaria categories. Furthermore it 
is associated with increase risk of death within this group. 
Maitland K (2005) et al detected that at the time of admission to the 
hospital, hyperkalemia may complicate cases of acidosis due to severe 
malaria and is associated with high, early mortality. Patients with fatal 
cases were significantly more frequently unconscious (213). 
It is also relevant to note that children with CM had significantly lower 
Hb level and higher bilirubin level and TWBCs count than those with 
UM.  
Mixed presentation: Four children in the study were found to have more 
than one WHO criteria of severe malaria. The table below shows the 
clinical features of this group. 
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Case No CM Repeated 
convulsions
Severe 
anaemia
Hypoglycemia
35 absent present present present
39 absent present absent present
73 present present present absent
82 present present absent present
This group had significantly lower RBG, Hb and higher bilirubin, total 
WBCs count and urea compared to children with UM.  
Idro et al (2007) from study in Kenya found that children having 
 hypoglycemia, acidosis, impaired perfusion, hyperparasitemia in 
association with neurological involvement  increased mortality and 
neurological sequelae (324).  
Maitland et al (2005) reported that children with higher median shock 
score, higher WBC count and worse metabolic derangements (acidosis, 
hypoglycemia, hyperkalaemia, and increased creatinine levels) had higher 
risk of death than those with lower levels of these parameters (213). 
Children having disseminated intravascular coagulopathy, cerebral 
malaria or hyperbilirubinemia in addition to renal impairment were found 
to have poor prognosis (281). Children with mixed presentation in this 
cohort had higher urea and creatinine in comparison to those with UM 
indicating renal impairment and poor prognosis.  
 
Potassium: In the study hyperkalaemia occured in 10.7% of SM cases 
and it is associated with increased mortality. A study in Kenyan children 
found that hyperkalaemia complicated falciparum malaria in 16% of 
whom 78% died soon after admission (213). 
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Table-34 Indicators of poor prognosis reported by some studies 
Parameter Ella-
Dzein
g et 
al(200
5)
Schellenb
erg et 
al(1999)
Marsh
et 
al(199
5)
Winkle
ret al 
(2008)
Maitlan
d et al 
(2005)
Abdulma
nnan et al 
(2006)
CM Yes - Yes Yes - Yes
Repeated 
convulsion
s
Yes - - - - -
Hypoglyce
mia
yes Yes - - Yes -
SA - - - - - -
Respiratory 
distress 
- yes yes Yes - -
Hyperkalae
mia
- - - - Yes -
Sodium - - - - - -
Urea - - - - - Yes
Creatinine - - - - yes yes
 
In conclusion, severe malaria is a multisystem disorder even when the 
most dramatic disorder appears to involve a single organ. Many 
pathophysiological mechanisms may act at the same time and at the same 
individual to result into the clinical category of severe malaria. 
Dysregulation of the immune system may have a critical role in 
determination of clinical category of malaria which was acquired by 
child. This shed light on genetic background which may affect the clinical  
presentation of the child. 
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CONCLUSIONS 
Age distribution 
1-Severe malaria is more common among children less than 5 years of 
age. 
2-Age correlates negatively with the outcome: more morbidity and 
mortality was found among the younger age group. 
3- Severe anaemia and repeated convulsions occurred in the younger age 
group. 
4- Cerebral malaria occurred in the older age group. 
5-Haemoglobinuria occurs in the older age group 
Blood glucose 
1- Children with severe malaria had significantly lower RBG than those 
with UM.  However it was still within the normal physiological range. 
2- Hypoglycemia was an infrequent complication which represented 7% 
of severe malaria cases. 
3- Higher parasitemia levels were significantly correlated with low blood 
glucose which may be due to consumption of the glucose by the parasites. 
4- Hypoglycemia alone was not associated with morbidity and mortality 
but when combined with other malaria complication it leads to increased 
risk of morbidity and mortality. 
5- IFN-γ correlates positively with blood glucose which suggest a role in 
counteracting hypoglycemia. This is a possibility due to its effect on 
release of ACTH and cortisol. IFN-γ was also found to induce spleen and 
liver enlargement which enhance their clearance of the parasites from the 
blood stream. 
Insulin & C-peptide 
1-No significant differences were found in the mean insulin and C-
peptide between children with uncomplicated and severe malaria.  
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2- Although ratio of I/C was lower in children with severe malaria, no 
significant difference was found when compared to the ratio of children 
with uncomplicated malaria. 
3- The expected value of insulin was much higher than the recorded value 
indicating a decreased half life of insulin in severe malaria. 
4- Insulin was positively correlated with RBG which indicates an 
appropriate response.  
5- Children with mixed presentation had a significantly higher C-peptide 
and lower I/C in comparison to those with uncomplicated malaria and 
those with single presentation which may be due to failure of renal 
excretion of C-peptide in this group of children.  
Haemoglobin  
1-Children with higher parasitemia level had significantly low Hb 
indicating direct hamolysis of parasitized RBCs as a cause of anaemia.  
2- IFN-γ and IL-10 correlate positively with Hb indicating the essential 
role of both cytokines in counteracting anaemia. 
3- Positive correlation was found between Hb and splenomgaly and 
hepatomegaly. This can be explained by removal of the parasites from 
infected RBCs without destroying them (biting function of the spleen). 
This result suggests that biting can occur in the liver also.  
Liver functions 
1- No significant difference in serum transaminases was found between 
UM and SM. 
2- Children with SM had a higher incidence of elevated transaminases 
indicating liver dysfunction. 
3- High levels of TNF-α and IFN-γ were found to associate with high 
serum transaminases l indicating involvement of these cytokines in 
mediation of liver pathology. 
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4-Children with severe malaria had unconjugated hyperbilirubinemia 
indicating haemolysis as the cause. Increased morbidity and mortality 
was associated with high levels of bilirubin. 
TWBCs 
1-Children with severe malaria had higher TWBCs count than those with 
UM. 
2- Children with increased morbidity and mortality had higher TWBCs 
count. 
3- Children with CM, repeated convulsions and mixed presentations had 
a significantly higher TWBCs count in comparison to those with UM 
indicating essential role of white blood cells in the pathogenesis of severe 
malaria through sequestration in the blood vessels or through secretions 
of excessive proinflammatory cytokines or toxins. 
Cytokines 
1. IFN-γ: IFN-γ was a hallmark of immunity against malaria as indicated 
by the following. 
• Children above 5 years had higher IFN-γ level than those less than 5 
years indicating that children produced more IFN-γ were protected 
against severe malaria. 
• Low levels of IFN-γ were associated with presentation of severe 
malaria.  
• Higher levels of IFN-γ were associated significantly with higher RBG 
and Hb. Children with severe anaemia had a significantly lower IFN-γ 
than those without severe anaemia. So IFN-γ protects children from two 
severe malaria categories; hypoglycemia and severe anaemia and this 
effect was most pronounced in early producers of IFN-γ. 
• IFN-γ correlates positively with splenomegaly and hepatomegaly 
which may improve their clearance of the parasite. 
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• Children with severe anaemia produced significantly lower IFN-γ than 
children with cerebral malaria and repeated convulsions. 
2. TNF-α 
• High level of TNF-α was associated with the risk of severe disease. 
Children below 5 years had significantly higher level than those above 5 
years. 
• Children with CM had a significantly higher level of TNF-α than 
those without CM indicating essential role of this cytokine in 
pathogenesis of CM. 
• Children with severe anaemia produced significantly lower TNF-α 
than those with cerebral malaria.  
3. IL-10 
• IL-10 is essential in prevention of SA development in children with 
malaria as IL-10 level was found to be low in SA and IL-10 correlate 
positively with Hb. 
• IL-10 correlate negatively with potassium. Activation of the stress 
axis may explain this finding. 
Renal functions 
Urea 
1- No significant difference in urea level was found between severe and 
uncomplicated malaria. 
2- Children with mixed presentation had a significantly higher urea level. 
In the presence of relatively high creatinine and sodium within this group, 
renal impairment may be explained by dehydration resulting in renal 
hypoperfusion. 
3- Children with increased morbidity had higher urea level than those 
with UM which indicates that renal impairment is an favorable prognostic 
factor. 
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Creatinine 
1-Children with severe malaria had lower creatinine level than those with 
UM suggests increased renal clearance. 
2-In the presence of hyponatremia and hypokalemia, low creatinine can 
be attributed to the syndrome of inappropriate ADH secretion, 
hyperdynamic circulation or both. 
Sodium   
1-Incidence of hyponatremia was more frequent in SM than in UM. This 
may indicate inappropriate ADH secretion in severe malaria. 
Potassium 
1-Incidence of hypokalaemia is more frequent in SM than in UM which is 
in favor of inappropriate ADH secretion. 
2-Hyperkalaemia was found in 10.7% of severe malaria cases.  
3-Most of children with hyperperkalaemia had neurological manifestation 
and increased mortality 
Indicators of morbidity and mortality 
1-cerebral malaria, mixed presentation, young age and high level of 
potassium were independently associated with increased risk of morbidity 
and mortality. 
2-Laboratory parameters significantly associated with cerebral malaria 
and mixed presentation were high bilirubin, TWBCs count, high urea, 
high creatinine and low Hb and low RBG.  
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RECOMMENDATIONS 
 
• Children with severe malaria should be admitted to an ICU facility 
where protocols of management of severe malaria are clearly 
defined. 
• Children with severe malaria aged below 5 years are at higher risk 
and should be offered special care. 
• Children with cerebral malaria and mixed presentation need to be 
monitored more intensively.  
• Potassium and sodium instability need to be monitored on 
admission and during the first 24 hours as frequently as possible.  
• RBG, Hb, urea, bilirubin estimation and TWBCs count should be 
done on admission for any child with severe malaria. 
• Studies linking the clinical presentation with genetic profile are 
recommended especially those related to cytokines receptors. 
• Studies of renal involvement in severe malaria are highly 
recommended. 
• A pilot study should be considered for children with severe 
anaemia to recieve treatment  with a combination of anti-parastic 
therapy, IFN-γ and IL-10 administration 
• A panel of experts is recommended to be set up by the Ministry of 
Health Malaria Program and the Sudan Association of 
Peadiatricians so as to revise the present protocol for management 
of severe malaria in the light of recent evidence from Sudanese and 
African studies. 
• Animal model are needed for more focused studies of the effects of 
cytokines. 
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APPENDIX 
University of khartoum 
Faculty of Medicine 
Department of Physiology  
Pathophsiology of severe malaria in children: clinical and laboratory 
correlations 
Questionnaire 
 
Name:  ……………………………………………………………………. 
Age: ……………………………………………………………………. 
Sex: ……………………………………………………………………… 
Residence: ………………………………………………………………... 
Informant: ……………………………………………………………... 
c/o: ………………………………………………………………………... 
History of present illness:  
 
 
Systemic review: 
cardiopulmonary system: 
Cough:     S.O.B:  
Gastrointestinal tract: 
Nausea:        Vomiting          Diarrhea:                  Abdominal pain  
central nervous system: 
Loss of consciousness       Duration>30 min   <30 min  
Convulsions:   Single:            Repeated:  
Urinary system 
Frequency of Micturition        Colour of Urine       Volume of Urine 
Abnormal bleeding sites 
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Past medical history: 
Previous attacks of malaria        Diabetes mellitus       
Any chronic illness 
physical examination 
Pallor Jaundice    Cyanosis 
Vital Signs: 
 PR           RR             Temperature  Wt 
Chest: 
Movement: Equal   Less in Rt                     Less in Lt 
Expansion: Equal             Less in Rt                   Less in Lt 
Trachea: Central           Deviated to Rt  Deviated to Lt 
Tactile focal fremitus---------- 
Breath sound:             Vesicular                   Bronchial 
Added sounds:    Crepitating                         Rhonchi 
cardiovascular system:     
apex beat                         Heart sound            Added sound                   
Heart failure 
Abdomen: 
 Distension                   Renal angles mass       Tenderness-----                          
Ascites  
Signs of hepatic failure: 
Foetur hepaticus          Flapping tremor               Liver span  
CNS: 
Level of consciousness                                       Cranial nerves                  
Motor and sensory systems                                Coordination 
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Investigation: 
 BFFM           Species       Parasitemia 
Hb                     TWBCs                         RBS 
 
Urine examination: 
Protein                      Sugar                Acetone                Hb 
Renal function test: 
S.creatinine             S.urea                S. NA+               S.K+ 
Liver function test: 
AST                           ALT                 Bilirubin 
Cytokines: 
IL-1                   IL-6  IL-10       IL-12  
TFN- α   
 Follow-up  
- General condition  
- PR 
- RR 
- Temp 
 
- Outcome  
Survived                                            Discharged in day 
  Died  in 1st day                          2nd day             on day 
 
 
  
 
 
 
 
 191
 
 
 
